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“Caminante, son tus huellas 
el camino y nada más; 
Caminante, no hay camino, 
se hace camino al andar. 
Al andar se hace el camino, 
y al volver la vista atrás 
se ve la senda que nunca 
se ha de volver a pisar. 
Caminante no hay camino 
sino estelas en la mar.” 
Antonio Machado 
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ABSTRACT 
Antioxidants constitute important cosmetic active ingredients capable of both protecting skin cells 
against the damaging effects of reactive species, as well as protecting cosmetic formulations against 
oxidative degradation. Recently interest has increased in finding natural antioxidants for cosmetic 
applications due to their strong activities and non-toxicity. Rosmarinic acid (RA) is a naturally occurring 
phenolic compound with a number of interesting biological activities, including antioxidant, anti-
carcinogenic, anti-inflammatory, amongst others, and is therefore a compound of interest for 
cosmetic applications. However transdermal delivery of RA through cosmetic formulations is a 
challenge due to various reasons, including instability, poor solubility in water and low partition 
coefficient, constraining the transport across biological barriers, the inclusion in a cosmetic 
formulation and the efficacy of the antioxidant. To circumvent these drawbacks microencapsulation 
technology has been proposed as a delivery system to increase stability, protect against degradation 
and to direct and control the release of active ingredients. Many encapsulation methods are described 
in the literature, but one of the most used in industrial applications is the spray-drying process, due 
to its low cost, availability of equipment and efficiency. Biopolymers and biodegradable polymers, 
such as chitosan, are the encapsulating materials with greater interest for cosmetic applications. 
The purpose of this study was to prepare and characterize chitosan and modified chitosan 
microparticles encapsulating RA by a spray drying technique, as means to overcome its limitation in 
cosmetic formulations, as well as to study the controlled release of RA from the particles under 
cosmetic formulation conditions (water and oil) and evaluate the antioxidant capacity. High 
performance liquid chromatography (HPLC) and UV-Vis spectrometry methods for RA determination 
were developed and validated. The methods presented good linearity with correlation coefficients 
greater than 0.999, and good precision results with coefficients of variation values lower than 5%. The 
limits of detection were 0.02 mg.L-1 for HPLC and 0.38 mg.L-1 and 0.25 mg.L-1 for UV-Vis spectrometry 
in water and oil, while the limits of quantification were 0.08 mg.L-1, 1.27 mg.L-1 and 0.83 mg.L-1, 
respectively. We concluded that is possible to encapsulate RA using different types of chitosan, 
through a spray-drying process. Satisfactory product yields of 42.6% and 39.8%, and association 
efficiencies of 92.6% and 59.6% were obtained for chitosan and modified chitosan particles. Spherical 
particles with mean diameters of 4.2 and 7.7 μm were obtained for chitosan and modified chitosan. 
Controlled release studies of RA showed a fast release (100% at 30 min) for modified chitosan particles 
in water, and a slower release (75% at 2 h) in oil. Chitosan particles showed a fast release (90% at 45 
min) in both mediums. Antioxidant assessment showed that chitosan-based microparticles did not 
compromise RA good antioxidant activity performance. As preliminary tests, the results in this study 
are significant and prove the success of RA microencapsulation for a topical delivery, but further 
studies need to be performed to obtain a more controlled and sustained release system. 
Keywords: Microencapsulation, rosmarinic acid, chitosan, controlled release, topical delivery 
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RESUMO 
Antioxidantes constituem importantes ingredientes ativos cosméticos capazes de proteger as células 
da pele contra os efeitos nocivos de espécies reativas, e de proteger as formulações cosméticas da 
degradação oxidativa. Atualmente o interesse em encontrar antioxidantes naturais para aplicações 
cosméticas tem aumentado, devido à sua forte atividade e não-toxicidade. O ácido rosmarínico (RA) 
é um composto fenólico natural com diversas propriedades de interesse: antioxidante, anti-
cancerígena, anti-inflamatória, etc., sendo um composto de interesse para aplicações cosméticas. No 
entanto, o transporte transdérmico do RA através de formulações cosméticas é um desafio, devido à 
instabilidade, baixa solubilidade em água e baixo coeficiente de partição, restringindo o seu transporte 
através de barreiras biológicas, a inclusão em formulações cosméticas e a eficácia do antioxidante. 
Para contornar estas questões têm sido propostas tecnologias de microencapsulação, que permitem 
melhorar a estabilidade, proteger contra a degradação e controlar e dirigir a libertação de compostos 
bioativos. Têm sido descritos diversos métodos de encapsulação, mas um dos mais usados em 
aplicações industriais é o processo de secagem por atomização, devido ao baixo custo, disponibilidade 
de equipamento e eficiência. Biopolímeros e polímeros biodegradáveis, como o quitosano, são os 
materiais encapsulantes de maior interesse para aplicações cosméticas. 
O objetivo deste estudo foi preparar e caracterizar micropartículas de RA encapsulado por quitosano 
e quitosano modificado pela técnica de secagem por atomização, como forma de transpor as suas 
limitações em aplicações cosméticas, assim como estudar a libertação controlada do RA sob condições 
de formulações cosméticas (água e óleo) e avaliar a capacidade antioxidante. Métodos de HPLC e 
espectroscopia UV-Vis para determinação do RA foram desenvolvidos e validados. Estes métodos 
apresentaram boa linearidade, com coeficientes de correlação superiores a 0.999, e boa precisão, 
com coeficientes de variação inferiores a 5%. Os limites de deteção foram 0.02 mg.L-1 para HPLC e 
0.38 mg.L-1 e 0.25 mg.L-1 para espectroscopia, em água e óleo, enquanto os limites de quantificação 
foram 0.08 mg.L-1, 1.27 mg.L-1 e 0.83 mg.L-1, respetivamente. Concluiu-se que é possível encapsular 
RA usando diferentes tipos de quitosano por secagem por atomização. Foram obtidos rendimentos 
de 42.6% e 39.8%, e eficiências de associação de 92.6% e 59.6%, para as partículas de quitosano e 
quitosano modificado. Produziram-se partículas esféricas com diâmetros médios de 4.2 e 7.7 μm. Os 
estudos de libertação controlada mostram uma rápida libertação (100% após 30 min) para as 
partículas de quitosano modificado em água, e uma libertação mais lenta (75% após 2 h) em óleo. As 
partículas de quitosano mostraram uma rápida libertação (90% aos 45 min) nos dois meios. A 
avaliação da atividade antioxidante mostrou que a encapsulação em partículas de quitosano não 
comprometeu a boa capacidade antioxidante do RA. Como testes preliminares os resultados obtidos 
são significativos e provam o sucesso da encapsulação de RA para aplicação tópica, mas mais estudos 
devem ser realizados para se obter um sistema de libertação mais controlado. 
Palavras-chave: Encapsulação, ácido rosmarínico, quitosano, libertação controlada, aplicação tópica 
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CHAPTER 1: INTRODUCTION 
1.1. Background 
Microencapsulation has been widely explored by the pharmaceutical, food, cosmetic, textile, 
personal care, chemical, biotechnology and biomedical industries. There are numerous 
possibilities to use microencapsulation as a technique to obtain products with high added value 
and therefore widespread interest has developed in microencapsulation technology (Hammad et 
al., 2011; Dubey et al., 2009; Wesselingh et al., 2007; Ghosh, 2006; Benita, 2005).  
The sector of cosmetics and personal care products has been evaluated in multi-billion dollars 
internationally and has shown great expansion in the global market. To have success in such a 
competitive and demanding sector, the products must differentiate (Euromonitor, 2011; Michael, 
2009). The skin-care and cosmetic formulators are being challenged to develop efficacious and 
clearly distinctive topical formulations and also include new bioactive ingredients, which can be 
achieved by means of using emergent technologies, such as microencapsulation. Numbers of 
materials as cosmetic active ingredients are being investigated such as antioxidants, vitamins, sun 
filters and natural plant extracts, namely essential oils and natural compounds (Kim et al., 2010). 
Meanwhile many of these cosmetic and personal care active ingredients are unstable and 
sensitive to temperature, pH, light and oxidation, and may undergo reactions that lead to the 
reduction or loss of its effectiveness or even to the degradation of the product. Thus, 
microencapsulation technologies have been proposed to increase stability, to protect against 
degradation, to direct and control the release of active ingredients used in cosmetic products, or 
even to mask undesired properties of the active components, such as their odour. In addition, 
the topical and transdermal delivery of cosmetic active ingredients requires safe, non-toxic and 
effective means to reach the target destination sites in the body. Therefore microencapsulation 
has been used in the development of cosmetic formulations that are more stable, more effective 
and with improved sensory properties, having found an increasing number of applications in this 
market (Pardeike et al., 2009; Soest, 2007; Sinko, 2006; Lumsdon et al., 2005; Rosen, 2005; 
Gallarate et al., 1999). Published patents in the area of microencapsulation suggest that both 
industrial and academic sectors are urging to explore this area, namely in the fields of cosmetics 
and personal care products for topical application (Conopco Inc. and D/B/A Unilever, 2010; 
Capsutech Ltd., 2009; Coreana Cosmetics Co. Ltd, 2001; Shaklee Corporation, 2001; Maybelline 
Intermediate Company, 1999; L’Oreal, 1998; Sunsmart, Inc. and Sibmicro Encapsulation 
Technologies, Inc., 1998; R.P. Scherer Corporation, 1996; Durand, 1995).  
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1.2. Cosmetic Ingredients 
1.2.1. Antioxidants in Cosmetics 
Antioxidants are molecules capable of inhibiting the oxidation of other molecules (Zheng et al., 
2001). Although oxidation reactions are essential for life, they can also be damaging, leading to 
cell injury and death. Topically applied antioxidants constitute an important group of cosmetic 
active ingredients capable of preventing the occurrence and reducing the severity of skin damage 
and aging (Oresajo et al., 2012; Wang et al., 2008). 
Skin, being the outermost barrier of the body, is frequently exposed to oxidative stress from 
exogenous sources (ultraviolet (UV) radiation, air pollutants, toxins) leading to the generation of 
reactive oxygen species (ROS) and free radicals. Owing to the presence of one unpaired electron 
in the outermost shell of the atomic nucleus, ROS and free radicals are highly reactive and have 
the affinity to either donate or obtain electrons from another species to achieve stability. This 
may lead to the oxidation and damage of biomolecules, including lipids, proteins and 
deoxyribonucleic acid (DNA). To counteract the harmful effects of free radicals, the skin possesses 
an antioxidant network responsible for maintaining the balance between these reactive species 
and antioxidants. The antioxidant network of the skin contains antioxidant species such as vitamin 
E, ubiquinones, carotenoids, vitamin C, uric acid and glutathione (Abla et al., 2013; Psotova et al., 
2006). Intrinsic and extrinsic free radical formation cause oxidative stress, the major and most 
important cause of skin damage. Intrinsic free radical formation occurs when the ability of human 
skin cells to repair DNA damage steadily reduces with years and the antioxidative defence 
becomes less effective (Poljsak et al., 2013). On the other hand, antioxidants present in the skin 
are susceptible to UV exposure and a single suberythemal dose1 can deplete their concentration 
in half, resulting in extrinsic free radical formation (Abla et al., 2013). Ionizing radiations, including 
UV radiation, are major environmental factors that dramatically alter skin homeostasis, causing a 
massive generation of cytotoxic reactive oxygen species and inducing DNA damage. Their 
cytotoxicity increases by interaction with membrane phospholipids, inducing peroxidative 
processes and the generation of lipoperoxy radicals (Sánchez-Campillo et al., 2009). Free radical 
formation and oxidative stress may lead to skin damage, premature skin aging, inflammatory 
reactions and malignant skin lesions (skin cancer) (Abla et al., 2013; Oresajo et al., 2012). Under 
these oxidative conditions the endogenous antioxidant system may be insufficient and exogenous 
agents with a strong antioxidant capacity could be beneficial (Sánchez-Campillo et al., 2009). 
                                                          
1 Threshold dose of radiation which, applied to the skin, may produce an erythema (sunburn). 
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Antioxidants are compounds that can delay or inhibit the oxidation of other molecules by 
inhibiting the initiation or propagation of oxidizing chain reactions (Zheng et al., 2001). 
Antioxidants act either by an indirect mechanism where they form chelates or by a direct 
mechanism where they donate an electron to the reactive oxygen species (Abla et al., 2013). 
Inhibition of propagating radicals during the oxidative chain reaction is believed to be the 
dominant mechanism by which phenolic antioxidants operate. A mechanism proposed to account 
for this behaviour is given in Figure 1 (Servili et al., 2014; Zheng et al., 2001; Basaga et al., 1997).   
 
Figure 1. Example of the mechanism of the antioxidant activity of phenols. 
Antioxidants protect skin cells against the damaging effects of reactive species, such as singlet 
oxygen, superoxide, peroxyl and hydroxyl radicals, thus preventing oxidative stress and skin aging 
and damage. Several studies concerning topically applied antioxidants have recently confirmed 
that antioxidant compounds can scavenge oxidative radicals, decrease lipid peroxidation and thus 
provide protection against oxidative stress. Therefore supplementing skin with antioxidants may 
strengthen the antioxidant capacity and reduce ROS induced skin damage (Abla et al., 2013). 
Moreover cosmetic products, which commonly comprise fats, oils and lipid containing matrices, 
are often prone to oxidation reactions, which generate compounds that cause rancidity, off-
aromas and activity losses (Carrillo et al., 2006; Basaga et al., 1997). Oxidative degradation of fats, 
oils and lipids is a major factor responsible for the deterioration of cosmetics and thereby for 
limiting the shelf life of these products. The use of antioxidants during the manufacturing process 
can provide protection against oxidative degradation of cosmetic products caused by free radicals 
(Wang et al., 2008; Aruoma et al., 1996). 
A variety of antioxidants can be used in topical cosmetic products. These include vitamin C 
(ascorbic acid and its derivatives), vitamin E (tocopherol and its derivatives), ubiquinones and its 
derivatives, and glutathione (GSH) and its precursors. In addition, activators of several enzyme 
systems that regenerate these antioxidants, such as GSH peroxidases and GSH reductase, and 
enzymes that neutralize ROS, such as superoxide dismutases, catalase, and quinone reductase, 
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are also used topically to potentiate antioxidant systems within the skin. Plant-derived 
compounds such as carotenoids and phenols are an important group of compounds showing 
antioxidant properties. Dozens of polyphenols have been shown to have antioxidant and anti-
inflammatory activities on the skin, and are currently used in skin care products (Oresajo et al., 
2012). In general there are three basic categories of antioxidants: natural, synthetic and semi-
synthetic. Recently, interest has increased considerably in finding naturally occurring antioxidants 
for cosmetic applications to replace synthetic ones, which are being restricted due to their 
carcinogenic effects (Zheng et al., 2001). 
Nevertheless, the efficacy and benefit of an antioxidant is very much dependent on the delivery 
of the antioxidant to the organism. When formulating with antioxidants, compatibility is a major 
concern. Care must be taken to protect the antioxidant from neutralizing other cosmetic active 
ingredients or from being neutralized under the conditions of the formulation. Product 
stabilization is also crucial. Since antioxidants can be very unstable, they may become oxidized 
and inactive before reaching the target body site. Antioxidants must also be absorbed into the 
skin, reach their target tissue in the active form, and remain there long enough to exert the 
desired effects (Oresajo et al., 2012). 
These issues can be solved by applying the microencapsulation technology, which provides the 
required technique for conversion of the antioxidant to an effective functional ingredient. The 
application of microencapsulated bioactive compounds as functional ingredients in cosmetic 
applications exhibits a significant potential, since it could enable the enrichment of various 
cosmetic products with natural antioxidants and its effective permeation through the skin. Owing 
to microencapsulated ingredients, the production of many products that were considered 
technically unfeasible has been enabled (Belščak-Cvitanović et al., 2011). 
1.2.2. Natural sources of compounds of cosmetic interest 
Herbs have been used for a large range of purposes including medicine, pharmaceuticals, 
nutrition, food preservation, flavourings, beverages, repellents, fragrances and cosmetics. Since 
prehistoric times, herbs were the basis for medicinal therapy until synthetic drugs were 
developed in the nineteenth century (Okoh et al., 2010; Zheng et al., 2001). In recent decades, 
the use of herbs and plants has been of great interest, as they have been the sources of natural 
products, commonly named as bioactive compounds (Zibetti et al., 2013; Wang et al., 2008). 
Bioactive compounds are natural active ingredients produced in plants as secondary metabolites 
that have an effect on a living organism, tissue or cell (Zibetti et al., 2013). The use of bioactive 
compounds from various herbs as functional ingredients in food, beverage and cosmetic 
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applications is gaining growing interest in the last few years (Belščak-Cvitanović et al., 2011). 
Natural matrices represent a rich source of biologically active compounds and are an example of 
molecular diversity, with recognized potential for the development of cosmetics or 
cosmeceuticals (Barroso et al., 2014). 
Bioactive compounds of plant origin have been shown to have several beneficial properties. 
Nowadays the use of natural compounds is also increasing around the world due to their mild 
features and low side effects (Belščak-Cvitanović et al., 2011; Sánchez-Campillo et al., 2009; Erkan 
et al., 2008). Cosmetic preparations from herbal origin are popular among consumers, as these 
agents are typically non-toxic and possess strong activities (Barroso et al., 2014). 
Herbs provide a wide spectrum of bioactive compounds with beneficial activities, namely 
polyphenols, vitamins, polysaccharides and minerals (Belščak-Cvitanović et al., 2011). Bioactive 
properties of various plants are connected with the presence of phenolic compounds, especially 
flavonoids. The biological, pharmacological and medicinal properties of this group of compounds 
have been extensively reviewed and related to their antioxidant properties by preventing UV 
induced oxygen free radical generation and lipid peroxidation. Many of these phytochemicals 
possess significant antioxidant capacities that have been associated with lower incidence and 
lower mortality rates of cancer (Zheng et al., 2001). Since oxidative stress is one of the major 
mechanisms for skin aging and damage, phytochemicals such as phenolic compounds could be 
useful for treating or preventing those conditions (Barroso et al., 2014; Luis et al., 2007). In order 
to prolong the storage stability of cosmetics and foods, synthetic antioxidants are used for 
industrial processing. But the toxicity effects of some synthetic antioxidants, such as butylated 
hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) have already been documented, and 
they include carcinogenic effects in living organisms (Türkoğlu et al., 2007). For this reason, 
governmental authorities and consumers are concerned about the safety and the potential 
effects of synthetic additives on health, and are demanding for natural ingredients. Preliminary 
studies demonstrated that some herbs extracts are as efficient as the synthetic antioxidants 
(Hernández-Hernández et al., 2009; Erkan et al., 2008; Wang et al., 2008). Phenolic compounds 
are also known to possess antimicrobial activity and are generally recognized as safe substances, 
therefore they are used to prevent post-harvest growth of native and contaminant bacteria (Okoh 
et al., 2010).  For all the described reasons in recent years a lot of interest has been devoted to 
exploring antioxidants from natural sources (Psotova et al., 2006; Basaga et al., 1997). 
Recently numerous reports have described antioxidants and compounds with beneficial activities 
present in fruits, vegetables, herbs and cereals extracts (Wang et al., 2008). Rosemary 
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(Rosmarinus officinalis), sage (Salvia officinalis), thyme (Thymus vulgaris) and lavender (Lavendula 
angustifolia) are native to the Mediterranean region and cultivated world-wide, and balm 
(Melissa officinalis) and spearmint (Mentha spicata) are common plants in Britain and other 
european countries.  Researchers have found that these plants are a source of compounds 
possessing high antioxidant, anti-inflammatory, antimicrobial and anti-carcinogenic activities. In 
particular rosemary extracts possess very useful antioxidant properties, which appear to be 
related to their content of phenolic compounds, amongst which rosmarinic acid was found to be 
one of the most important (Hernández-Hernández et al., 2009; Erkan et al., 2008; Wang et al., 
2004; Aruoma et al., 1996). Gachkar et al. (2007) reported the chemical composition, 
antibacterial, antioxidative and radical-scavenging properties of the essential oils of Rosmarinus 
officinalis and Cuminum cyminum obtained by steam distillation. The antimicrobial activity of 
essential oils obtained from oregano, thyme, sage, rosemary, clove, coriander, garlic and onion 
against both bacteria and fungi has also been reported (Okoh et al., 2010). 
The inclusion of antioxidants, or rich sources thereof (including herb extracts), in cosmetics is 
becoming a common procedure of this industry, namely in the production of various cologne 
waters, body lotions and creams, sunscreens, bathing lotions, hair lotions, shampoos and as 
components of disinfectants and insecticides (Campos et al., 2012; Okoh et al., 2010; Sánchez-
Campillo et al., 2009; Wang et al., 2004). 
Rosemary - Rosmarinus officinalis 
Rosmarinus officinalis (Figure 2), commonly known as rosemary, is a perennial herb that belongs 
to the Lamiaceae family (Sui et al., 2012; Okoh et al., 2010; Kim et al., 2001). It is native to the 
Mediterranean region in countries like Portugal, Spain, Morocco, Tunisia and Italy, but is now 
widely distributed and has been cultivated in many regions (Fernandes et al., 2013; Liu et al., 
2011). Rosemary extracts have been used for thousands of years as flavourings, pharmaceuticals, 
alternative medicine and natural therapies (Couto et al., 2012; Zu et al., 2012; Fadel et al., 2011).  
 
Figure 2. Rosemary (Rosmarinus officinalis) (The Herb Society of America, 2009). 
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Recently rosemary has been largely studied as a source of natural products with diverse biological 
activities (Visentin et al., 2012). In addition to being used as a food flavouring, several extracts, 
essential oils and chemical constituents isolated from Rosmarinus officinalis demonstrated a 
number of interesting biological activities, including antioxidant, antimicrobial, anti-
inflammatory, anti-tumorigenic, anti-allergic, metal chelating, chemo-preventive and cyto-
protective activities (Couto et al., 2012; Sui et al., 2012; Liu et al., 2011; Wang et al., 2004), which 
makes them suitable candidates as bioactive ingredients to design functional cosmetic, 
pharmaceutical and food products (Visentin et al., 2012; Zu et al., 2012; Psotova et al., 2006). 
R. officinalis has been widely accepted as one of the spices with highest antioxidant activities of 
all the herbs and spices that have been investigated (Wang et al., 2008). The antioxidant activity 
of rosemary is related to rosemary’s content of polyphenolic compounds (Couto et al., 2012; Del 
Bano et al., 2003). The compounds associated with the antioxidant activity of the herb are the 
phenolic acids such as rosmarinic acid, ursolic acid and caffeic acid, and the phenolic diterpenes 
such as carnosoic acid, carnosol, rosmanol, epirosmanol and methyl carnosate (Table 1) (Zibetti 
et al., 2013; Carvalho et al., 2005¸ Del Bano et al., 2003). In addition, several flavonoids, such as 
genkwanin, scutellarein, cirsimaritin and luteolin have been identified (Table 1) (Del Bano et al., 
2003). Several studies have indicated that the most active antioxidant compounds in rosemary 
are the diterpene, carnosic acid, and the phenolic acid, rosmarinic acid, which are the most 
abundant constituents and also well known for their various biological properties (Sui et al., 2012; 
Liu et al., 2011; Luis et al. 2007). Rosmarinic acid is the major and most important phenolic 
component of the plant and is therefore considered a chemical marker of this species. It exhibits 
a wide spectrum of biological activities, mainly antioxidant and anti-carcinogenic (Couto et al., 
2012; Psotova et al., 2006; Wang et al., 2004).  
Rosmarinic acid 
Rosmarinic acid (RA) is a naturally occurring phenolic compound commonly found in plants 
belonging to the Boraginaceae family and the subfamily Nepetoideae of the Lamiaceae family 
(Campos et al., 2014; Sánchez-Campillo et al., 2009). RA was originally isolated in 1958 from the 
rosemary plant (Rosmarinus officinalis). Some of the species from which this compound has been 
reported include rosemary (Rosmarinus officinalis), sage (Salvia officinalis), peppermint (Mentha 
piperita), thyme (Thymus vulgaris), marjoram (Origanum vulgare), basil (Ocimum basilicum) and 
Prunella (Prunella vulgaris) (Hossan et al., 2014; Kim et al., 2010). 
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Table 1. Properties and biological activities of rosemary (Rosmarinus officinalis) antioxidants. 
Compound 
IUPAC Name 
CAS Number 
Molecular Formula 
Chemical Structure Natural Occurrences 
Solubility 
(mg.mL-1) 
Biological activities 
Rosmarinic acid 
(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-
dihydroxyphenyl)prop-2-enoyl]oxypropanoic 
acid 
20283-92-5 
C18H16O8 
 
Rosmarinus officinalis 
Salvia officinalis 
Mentha piperita 
Thymus vulgaris 
Origanum majorana 
Ocimum basilicum 
Prunella vulgaris 
Ethanol: 25 
DMSO: 25 
DMF: 25 
PBS: 15 
Water: 1.0 
Antioxidant 
Anti-inflammatory 
Anti-bacterial 
Anti-viral 
Anti-carcinogenic 
Anti-angiogenic 
Anxiolytic 
Neuro-protective 
Carnosic acid 
(4aR,10aS)-5,6-Dihydroxy-1,1-dimethyl-7-
propan-2-yl-2,3,4,9,10,10a-
hexahydrophenanthrene-4a-carboxylic acid 
3650-09-7 
C20H28O4 
 
Rosmarinus officinalis 
Salvia officinalis 
 
Ethanol: 30 
DMSO: 30 
DMF: 30 
Water: 1.0 
 
Antioxidant 
Anti-microbial 
Anti-angiogenic 
Anti-carcinogenic 
Ursolic acid 
(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-
hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-
2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-
tetradecahydro-1H-picene-4a-carboxylic acid 
77-52-1 
C30H48O3 
 
Rosmarinus officinalis 
Mirabilis jalapa 
Lavandula spica 
Mentha piperita 
Ocimum basilicum 
Ethanol: 5.0 
DMSO: 25 
DMF: 25 
 
Antioxidant 
Anti-carcinogenic 
Anti-angiogenic 
Cardio-protective 
Carnosol 
(7β)-11,12-Dihydroxy-7,20-epoxyabieta-
8,11,13-trien-20-one 
5957-80-2 
C20H26O4 
 
Rosmarinus officinalis 
Salvia pachyphylla 
Ethanol: 8.0 
DMSO: 25 
DMF: 35 
PBS: 0.030 
Water: 0.0014 
Antioxidant 
Anti-inflamatory 
Anti-angiogenic 
Anti-carcinogenic 
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Rosmanol 
(6β,7β)-7,11,12-Trihydroxy-6,20-epoxyabieta-
8(14),9(11),12-trien-20-one 
80225-53-2 
C20H26O5 
 
Rosmarinus officinalis n.d. 
Antioxidant 
Anti-inflamatory 
Anti-carcinogenic 
 
Methyl carnosate 
methyl (4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-
7-propan-2-yl-2,3,4,9,10,10a-
hexahydrophenanthrene-4a-carboxylate 
82684-06-8 
C21H30O4 
 
Rosmarinus officinalis 
Salvia officinalis 
 
n.d. 
Antioxidant 
Anti-bacterial 
 
Genkwanin 
5-hydroxy-2-(4-hydroxyphenyl)-7-
methoxychromen-4-one 
437-64-9 
C16H12O5 
 
Rosmarinus officinalis 
Alnus glutinosa 
Notholaena bryopoda 
Asplenium normale 
Teucrium 
ramosissimum 
Soluble in: DMSO, DMF 
Antioxidant 
Anti-carcinogenic 
 
Scutellarin 
5,6,7-trihydroxy-2-(4-hydroxyphenyl)-4H-
chromen-4-one 
27740-01-8 
C21H18O12 
 
Rosmarinus officinalis 
Scutellaria barbata 
Scutellaria lateriflora 
Soluble in: alkali hydroxides, 
glacial acetic acid 
DMSO: 1.0 
Antioxidant 
Anti-carcinogenic 
Cirsimaritin 
5-hydroxy-2-(4-hydroxyphenyl)-6,7-
dimethoxychromen-4-one 
6601-62-3 
C17H14O6 
 
Rosmarinus officinalis 
Teucrium 
ramosissimum 
Lemon verbena 
Cirsium vulgare 
n.d. 
Antioxidant 
Anti-carcinogenic 
n.d.: not described; IUPAC: International Union of Pure and Applied Chemistry; CAS: Chemical Abstracts Service; DMSO: Dimethyl sulfoxide; DMF: Dimethyl formamide; PBS: Phosphate buffered saline 
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Rosmarinic acid (Table 2) is formally known as (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4 
dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid (Hossan et al., 2014). It is a white-yellow 
powder slightly soluble in water, but well soluble is most organic solvents (Kim et al., 2010). 
Table 2. Chemical and physical properties of rosmarinic acid. 
Chemically, RA is an ester of caffeic acid (CA) and 3,4-dihydroxyphenyllactic acid, being a CA dimer 
formed by esterification (ester condensation) of CA and its hydrated derivative 3,4-
dihydroxyphenyllacetic acid. Biologically, the biosynthesis of RA starts with precursor molecules 
L-phenylalanine and L-tyrosine and uses 4-coumaroyl-CoA (coenzyme A) from the general 
phenylpropanoid pathway as hydroxycinnamoyl donor (Appendix A: Biosynthetic pathway of 
rosmarinic acid) (Petersen et al., 2013, 2009, 1993; Sundaram et al., 2010). In plants, RA acts as a 
preformed constitutively accumulated defence compound (Sánchez-Campillo et al., 2009).  
Rosmarinic acid was reported to have a number of interesting biological activities (Campos et al., 
2014). RA has anti-inflammatory and anti-allergic properties, inhibiting several inflammatory 
processes by direct effects on T cells (Stansbury et al., 2012; Sánchez-Campillo et al., 2009). This 
compound possesses antiviral, including against herpes simplex virus and human immune-
deficiency virus type one (HIV-1), and antibacterial activities (Gudzenko, 2013; Fecka et al., 2007). 
Compound (Acronym) Rosmarinic acid (RA) 
IUPAC Name 
(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-
dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid 
CAS Number 20283-92-5 
Molecular Formula C18H16O8 
Chemical Structure 
 
Molar mass (g.mol-1) 360.31 
Melting point (°C) 173                                                                                                                 
Density 1.55 
Vapor pressure (mm Hg) 1.10 x 10-13 
log Kow 1.82 
pKa 3.57 
UV absorption max (nm) 221, 291, 330 
Solubility (mg.mL-1) Ethanol: 25 
DMSO: 25 
DMF: 25 
PBS: 15 
Water: 1.0 
INTRODUCTION 
 
11 
 
Rosmarinic acid was reported to possess notable activity against Bacillus subtilis and Escherichia 
coli. It has also been reported to possess activity against Pseudomonas aeruginosa, Shigella sp, 
Staphylococcus aereus, Enterobacter, Candida albicans and Aspergillus niger.  In vivo studies have 
shown that RA also exhibits anti-angiogenic, anxiolytic, anti-atherosclerotic, anti-fibrotic, chemo-
protective and neuro-protective activities, as well as reduction of atopic dermatitis and 
prevention of Alzheimer’s disease (Bhatt et al., 2014; Silva et al., 2014b; Gudzenko, 2013; Kelsey 
et al., 2010; Swarup et al., 2007; Sanbongi et al., 2004, Hooker et al., 2001). However the most 
important activities of RA are the antioxidant and anti-carcinogenic effects (Campos et al., 2014). 
RA has a potent antioxidant activity, stronger than that of vitamin E, by scavenging oxygen free 
radicals, delaying vitamin E depletion, preventing the oxidation of low density lipoproteins and 
providing photo-protection of keratinocytes (Kim et al. 2010; Sánchez-Campillo et al., 2009). RA 
helps to prevent cell damage caused by free radicals, thereby reducing the risk of cancer (Kim et 
al., 2010). RA has been found to be effective against a number of cancer cell lines, including skin 
cancer and melanoma, colon cancer, leukaemia and breast cancer (Osakabe et al., 2004). The 
effects of skin cancer have been reversed by topical application of RA, which acted against skin 
tumours by exerting an anti-inflammatory and antioxidant effect. RA was found to have dual anti-
carcinogenic capability, namely that of protecting normal cells against radiation but also of 
sensitizing melanomas to radiation (Alcaraz et al., 2014; Hossan et al., 2014). 
Rosmarinic acid is therefore a compound of interest for cosmetic applications. However, 
transdermal delivery of this antioxidant through cosmetic formulations, such as emulsions and 
creams, is a challenge due to instability, discoloration, poor solubility in water and low partition 
coefficient, constraining the transport across biological barriers. The technological handling of 
such type of compounds is sometimes limitative due to their reactivity, so their incorporation in 
a cosmetic formulation becomes difficult if they are not duly protected from the interactions to 
which they are exposed when incorporated in cosmetic matrices. The solubility characteristics of 
the antioxidant in relation to the site of action must also be considered (Campos et al., 2014, 
2012; Silva et al., 2014b; Visentin et al., 2012; Kim et al., 2010). In view of the above mentioned 
drawbacks, encapsulation with an appropriate carrier material for RA delivery, protection and 
release is necessary to obtain an effective product (Silva et al., 2014b). Encapsulation will protect 
the antioxidant during manufacturing processes, improve its long-term stability, its permeability 
characteristics through the skin and the retention within the skin, and increase the efficacy of the 
compound (Budhiraja et al., 2014; Campos et al., 2012; Visentin et al., 2012). Among different 
approaches explored so far, microparticles, especially those made of biocompatible polymers, 
such as chitosan, seem to assure active and safe delivery of this compound (Silva et al., 2014b). 
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1.3. Microencapsulation 
Microencapsulation is a process of encapsulating a material containing an active ingredient (core 
material) in a shell of a second material (encapsulating/wall material) for the purpose of shielding 
active ingredients from the surrounding environment permanently or temporarily. This results in 
small capsules of many useful properties, termed microcapsules or microparticles. Such particles 
have diameters between one micron and a few millimetres. Particles whose diameter is in the 
nanometre range are referred to as nanoparticles (Kaur et al., 2013; Jyothi et al., 2010, Benita, 
2005). The small size of these particles provides a large surface area that is available for sites of 
adsorption/desorption, chemical reactions, light scattering, etc. (Arshady, 1999; Gutcho, 1976).  
The development of microencapsulation began with the preparation of capsules containing dyes 
in 1950s by Green and Schleicher. These were incorporated into paper for copying purposes and 
replaced carbon paper. Nowadays this approach has been widely explored by the pharmaceutical, 
food, cosmetic, textile, agricultural, veterinary, chemical and biomedical industries (Hammad et 
al., 2011; Ghosh, 2006). The field with the highest level of microencapsulation applications is the 
drug sector (68%), followed by food (13%) and cosmetics (8.0%) (Martins et al., 2014). There are 
numerous possibilities to use microencapsulation as a technique to obtain products with high 
added value and therefore widespread interest has developed in microencapsulation technology 
(Martins et al., 2014; Dubey et al., 2009). 
Core materials in microcapsules may exist in the form of a solid, liquid or gas. Depending on the 
application, a wide variety of core materials can be encapsulated, including pigments, fragrances, 
flavours, enzymes and cells. The size of the core material plays an important role for diffusion, 
permeability and controlled release. The shell material can be permeable, semi-permeable or 
impermeable. Compatibility of the core material with the shell is an important criterion for 
enhancing the efficiency of the microencapsulation, and for this pre-treatment of the core 
material is often carried out (Estevinho et al., 2013a; Hammad et al., 2011; Ghosh, 2006). 
The morphology of the internal structure of a microcapsule (Figure 3) depends largely on the 
selected shell material and the encapsulation method employed. Microcapsules can be classified 
as mononuclear, polynuclear or matrix type. Mononuclear microcapsules contain the shell 
around the core and have a single hollow chamber within the capsule. Microcapsules can also be 
mononuclear with multiple shells. The polynuclear microcapsules have many cores enclosed 
within the shell, so they have a number of different sized chambers. The matrix type microparticle 
has the active ingredients integrated within the matrix of the shell material and distributed 
homogeneously (Chhotalal et al., 2013; Dubey et al., 2009; Ghosh, 2006). 
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Figure 3. (a) Scheme of a microcapsule. (b) Morphology of microcapsules. (Adapted from Ghosh, 2006) 
Microcapsules are usually characterized by parameters such as particle size, zeta potential, 
encapsulation efficiency and drug loading (Estevinho et al., 2013a). The size and shape of the 
microparticles can be determined by light or scanning electron microscope (LM or SEM). 
Encapsulation or association efficiency (content of core material effectively encapsulated) 
depends on several variables. The retention of the active agent inside the shell is determined by 
the chemical nature of the core (molecular weight, chemical functionality, polarity and volatility), 
shell material properties and the encapsulation technique (Selvaraj et al., 2012; Jyothi et al., 2010; 
Martins et al., 2010; Gander et al., 1995). Microcapsule solvation, density, compressibility index, 
Hausnner’s ratio2 and angle of repose can also be determined (Hammad et al., 2011).  
Microcapsules have a number of interesting advantages, thus microencapsulation technology is 
used for several purposes: to combine properties of different materials (e.g. organic and 
inorganic);  to protect sensitive, unstable and reactive materials from their environments and 
prevent the degradation of active compounds (e.g. from reactions like oxidation and 
dehydration); to protect the immediate environment of the microcapsules from the active 
components; to increase stability; for controlled, delayed  or sustained release; to reduce dosing 
frequency; for enzyme and microorganism immobilization; to mask undesired properties of the 
active components (such as odour, taste and activity); for a targeted release of encapsulated 
materials; for better processability, as it allows to improve solubility, dispersibility and flowability; 
for a safe and convenient handling of toxic materials; and to separate incompatible components 
for functional reasons. Some application examples of the use of microencapsulation technology 
are isolating vitamins from the deteriorating effects of oxygen, retarding evaporation of a volatile 
core, improving the handling properties of a sticky material or isolating a reactive core from 
chemical attack (Ramu et al., 2014; Ghosh, 2006; Lopéz et al., 1997). 
                                                          
2 Index of flow ability of microcapsules. 
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1.3.1. Microencapsulation techniques 
 Although a variety of techniques have been reported for microencapsulation, no single process 
is adaptable to all core materials or product applications. The choice of the most suitable method 
depends on the application of the microsystem, particle size required, physical and chemical 
properties of the core and the shell, release mechanism intended, production scale and costs. An 
appropriate combination of starting materials and synthesis methods can be chosen to produce 
encapsulated products with a wide variety of compositional and morphological characteristics, 
and the encapsulation process must be optimized in order to provide a satisfactory outcome, 
considering the intended application. Microencapsulation techniques can be broadly divided into 
two main categories, namely chemical and physical, with the latter being further subdivided into 
physico-chemical and physico-mechanical techniques (Silva et al., 2014a; Estevinho et al., 2013a; 
Wilson et al., 2007). Table 3 outlines common methods used to encapsulate ingredients and the 
size of particles they produce. Such methods have been described by Silva et al. (2014a), Dubey 
et al. (2009), Fairhurst et al. (2008), Wilson et al. (2007) and Ghosh (2006). 
 Table 3. Usual methods for microencapsulation and respective particle size produced. 
 Spray drying is one of the most common methods used for microencapsulation. It is a continuous 
and single-cycle process that involves the conversion of a material from a fluid state (solution, 
emulsion or suspension) into a dried particulate form by atomization in a hot gas medium 
(generally air) (Estevinho et al., 2014b, 2013a, 2013b). The ingredient to be encapsulated is added 
to the carrier (the ratio of core to carrier can be optimized for each individual ingredient) and the 
Type of Method Method 
Particle size 
(μm) 
References 
Chemical process 
Emulsion Polymerization 0.5–1000 
Fairhurst et al., 2008; 
Ghosh, 2006; Hirech, 2003 
Suspension Polymerization 0.5–1000 
Interfacial Polymerization 0.5–1000 
Physico-chemical 
process 
Coacervation/Phase separation 1–1000 Fidalgo et al., 2013; Di 
Marco et al., 2010; Cocero 
et al., 2009; Martins et al., 
2009; Nguyen-Ngoc et al., 
2007; Ghosh, 2006; Freitas 
et al., 2003 
Solvent evaporation/extraction 0.5–1000 
Sol-gel encapsulation 2–20 
Supercritical fluid-assisted 
microencapsulation 
0.5-500 
Layer-by-layer assembly 0.5–20 
Physico-mechanical 
process 
Spray-drying 1–500 
Fernandes et al., 2014, 
2013; Shinde et al., 2014; 
Teodoro et al., 2014; 
Anwar et al., 2010; 
Fairhurst et al., 2008; 
Ghosh, 2006; Senuma et 
al., 2000 
Spray-cooling 20 – 500 
Co-extrusion 250–2500 
Spinning disk 5–1500 
Fluidized-bed coating 20–1500 
Melt solidification 5-1000 
Polymer precipitation 5-1000 
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mixture is homogenized. An emulsifier or cross-linking agent may also be added at this stage. This 
mixture is then fed into the spray dryer with circulating hot air and atomized, which can be made 
by different types of atomizers: pneumatic atomizer, pressure nozzle, spinning disk, fluid nozzle 
and sonic nozzle. The solvent is evaporated by the hot air and the shell material encapsulates the 
core. Small particles are deposited in the collection vessel where they are collected (Fernandes 
et al., 2014, 2013; Teodoro et al; 2014; Chávarri, 2012; Wilson et al., 2007). A representation of 
the spray drying process and an image of the equipment are presented in Figure 4. 
    
Figure 4. Scheme (Adapted from Chávarri, 2012) and photography of the spray-drying process/equipment.  
The properties of the final microparticles depend on the nature of the feeding flow as well as the 
operating parameters, such as flow rate and inlet temperature. Hot air inlet temperature is 
typically 150-220 °C and after evaporation the temperature decreases typically to moderate 
values between 50 and 80 °C. Spray drying can produce, depending on the starting feed material 
and operating conditions, particles with a size between 1 and 500 µm. Increasing the energy 
provided to the atomizer decreases the size of the formed particles. For the same energy amount, 
the size of the particles increases with increasing feed rate. On the other hand, the size of particles 
also increases with the viscosity and surface tension of the feeding liquid. The microcapsules 
produced are normally of the polynuclear or matrix type and the mechanisms of release involved 
are typically controlled by solvents action and diffusion (Estevinho et al., 2014, 2013a; De Vos et 
al., 2010; Gharsallaoui et al., 2007; Azeredo, 2005). 
The shell material, which is hydrated in water, should therefore be soluble in water, have good 
emulsifying properties, be a good film former, have low viscosity and provide good protection to 
the encapsulated ingredient. Water-soluble polymers are mainly used as shell materials due to 
the fact that solvent-borne systems produce unpleasant odours and environmental problems. 
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Typical shell materials used in spray drying include chitosan, sodium alginate, gum arabic, 
maltodextrins, modified starch, and mixtures of these. The use of encapsulating agents with low 
solubility in water implies an increase in the amount of water to be evaporated, and thereby a 
decrease in the dry matter content and in the amount of active ingredient, resulting in a costly 
process (Estevinho et al., 2013a; Wilson et al., 2007; Ghosh, 2006). 
Spray drying has advantages over other encapsulation methods: large equipment availability, 
possibility of employing a wide variety of encapsulating agents, easy control of microparticle 
properties by changing the operational parameters, easy scale-up and large-scale production, low 
process cost and it is a rapid methodology, reproducible and cost-effective, justifying its use in 
industrial applications (Estevinho et al., 2014, 2013a, 2013b, 2012; Fernandes et al., 2014; Jafari 
et al., 2008, 2007). Moreover the process is adaptable to a wide range of feedstock and product 
specifications, as it can be used with solutions, suspensions, slurries, melts and pastes. 
Microencapsulation by spray drying is thus a simple and low cost commercial process that has 
been used to encapsulate mainly flavours (Estevinho et al., 2013a), oils and pigments, but also 
thermo-sensitive products, such as microorganisms, enzymes and essential oils, due to the very 
short heat contact time and the high rate of evaporation, resulting in high quality, stable, 
functional and low moisture content products. Biologically active materials have been 
successfully spray dried without appreciable activity losses (Estevinho et al., 2014a, 2014b, 2013a, 
2013b, 2012; Fernandes et al., 2013). 
1.3.2. Microencapsulation in cosmetics 
Delivery systems and microcapsules play an important and growing role in the cosmetics and 
personal care industries nowadays. They offer an ideal and unique carrier system for active 
ingredients, allowing the controlled and targeted release, isolation and protection of the active 
compounds, improved stability and efficacy, safe administration, to mask undesirable properties 
of the active components, such as their odour, and also the improvement of the tactile and visual 
appearance of a variety of cosmetic and personal care products. In these industries there is a 
constant look for new and novel delivery systems to safely incorporate many of the new and 
sensitive active ingredients of the cosmetic products. Finding new delivery systems can allow an 
easier and simpler use and development of critical emulsion systems, where temperature and 
water/oil content are very important and sensitive active ingredients must be added in a special 
and sometimes very difficult way or under very controlled conditions. Microencapsulation has 
the potential of delivering active ingredients in some difficult systems, e.g. containing glycolic 
acid, alpha hydroxy acids (AHAs), salicylic acid, high alcohol content or critical water-in-oil or 
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silicone emulsions. They can be used to deliver active ingredients into the skin, in a safe, targeted, 
effective and not painful manner, to protect fragrances or volatile compounds from evaporation, 
to protect compounds such as antioxidants from oxidation, to protect from degradation caused 
by heat, light and moisture, or to control the release rate (Martins et al., 2010; Pardeike et al., 
2009; Soest, 2007; Rosen, 2005). Recent published patents in the area of microencapsulation 
suggest that both industrial and academic sectors are urging to explore this area, namely in the 
fields of cosmetics and personal care products (Martins et al., 2014). 
Microencapsulation can be used in cosmetic applications for shower and bath gels, lotions and 
creams, hair products, sunscreens and tanning creams, makeup, perfumes, soaps, tooth pastes 
and more. Its study and development may help in the improvement of the cosmetic and personal 
care industries, as microencapsulation technology brings innovation and allows the production of 
high added value products, in response to human needs and desires (Barel et al., 2001). 
1.3.3. Delivery systems for topical application 
The skin is the largest and most complex human organ, with at least five different cell types 
contributing to its structure and representing 16% of total body weight (2 m2 of surface). The 
main function of the skin is the protection of the body, which includes physical, chemical and 
immunological protection, protection against pathogens, and UV radiation and free radical 
defences. It is also the major participant in thermoregulation, it functions as a sensory organ and 
it performs endocrine functions. Human skin is comprised of several distinct layers, namely the 
stratum corneum (epidermis), the remaining layers of the epidermis, the dermis and the sub-
cutaneous adipose tissue (hypodermis). The epidermis is the outer layer and acts as a protective 
coating against environmental and external influences. It consists of several layers starting with 
the stratum corneum to the basal cell layer, and is continually being regenerated. The dermis lies 
beneath the epidermis and is where collagen and elastin are synthesized. It contains the blood 
vessels, nerves, sweat glands, hair follicles and sebaceous glands. The hypodermis contains the 
adipose tissue (sub-cutaneous fat) and provides a thermal barrier. The structure of the skin is 
represented in Figure 5a. The stratum corneum is the upper 10–20 µm layer, which is a lipid-rich 
matrix composed primarily of ceramides, cholesterol and fatty acids that are assembled into a 
multi-lamellar bilayer structure. The structure of the stratum corneum comprises protein rich 
cells (corneocytes) embedded into the intercellular lipid domains. Corneodesmosomes act to link 
neighboring corneocytes together and provide structural integrity to the stratum corneum. The 
structure of the stratum corneum is represented in Figure 5b (Ammala, 2013; Harding, 2004). 
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Figure 5. Schematic representation of a) human skin; b) stratum corneum. (Adapted from Harding, 2004) 
A delivery system is a method of holding, carrying and transporting an active ingredient. It is any 
type of vehicle that takes an active to a target site. A delivery system can control the release rate 
of an active ingredient from a formulation at an optimal rate. A number of pathways are possible 
for the transportation of molecules through the skin. The intercellular route occurs at the 
interface between cells through the lipid bilayers, following a tortuous permeation pathway. In 
contrast, transcellular pathways can occur directly through the cells. Transportation via the hair 
follicles or sweat ducts is also possible (Wiechers, 2008; Flynn, 2002; Moghimi et al., 1999). 
Topical application of cosmetic formulations often requires the successful delivery of active 
ingredients through the skin’s barriers to reach the target sites in the body. The main resistance 
to transdermal transport is in a layer of cells joining the epidermis to the stratum corneum, which 
itself also limits the transport. The stratum corneum has a highly impermeable nature, which has 
remained one of the major challenges in effective transdermal delivery. While the lipophilic 
stratum corneum contains about 13% water, the inner skin epidermis layers become significantly 
more hydrophilic, containing 50% water, while the dermis contains 70%. It is of extreme 
importance to understand these properties to design carriers to achieve the desired delivery of 
cosmetic active substances. It should also be noted that there are wide variations in permeability 
at different body sites (e.g. face vs. legs vs. palms) which together with factors such as age and 
external environment can influence the skin’s barrier function (Lam et al., 2014; Forster et al., 
2009; Wiechers, 2008; Elias, 2004; Harding, 2004; Rein, 1924). 
It is generally reported that the transport of molecules through the epidermis is restricted to 
molecules of low molecular mass (<500 Da) and moderate lipophilicity (partition coefficients log 
Kow values between 2 and 3), having enough solubility in the lipid domain of the stratum 
corneum, while still having sufficient hydrophilic nature to allow partitioning into the skin inner 
layers. As some active cosmetic substances are too hydrophilic to pass through the stratum 
corneum or too lipophilic to partition into the epidermis, encapsulation techniques with the right 
shell materials can overcome this problem by delivering the level of lipophilicity needed for the 
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desired application. Mathematical models can be used to predict skin permeability, which are 
generally based on quantitative structure-permeability relationships (QSPR), diffusion 
mechanisms or combinations of both. At the same time the compound should still have the 
lipophilic or hydrophilic characteristics that allow its solubilisation in the cosmetic itself and 
ensure its stability during formulation, storage and application of the product (Ammala, 2013; 
Forster et al., 2009; Jain et al., 2006; Wiechers, 2005; Barry, 2002; Muller et al., 2002, 2000). 
Critical aspects should be considered when delivering a cosmetic active ingredient through the 
skin, such as the right site of action of the cosmetic ingredient, the right concentration of the 
components, and the correct application time of the product on the skin. It should be considered 
the influence of the formulation type, formulation polarity, stratum corneum polarity, skin lipid 
organization and the influence of particle size on skin delivery. The cosmetic delivery should also 
avoid undesirable transdermal delivery, such as leakage into systemic circulation, and keep the 
functional molecule in a specific skin layer (Abla et al., 2013; Wiechers, 2008; Fu et al., 2005). 
Common functional ingredients used in topical application cosmetics are UV filters, antioxidants, 
moisturizers, skin lightening ingredients, and molecules with anti-aging properties, acting either 
on the surface of the skin or in specific skin layers (Ammala, 2013; Wiechers, 2008; Elias, 2004). 
Several skin delivery systems used in cosmetic products have been reported. Vesicles and 
niosomes (non-ionic surfactant-based vesicles) are much used as skin delivery vehicles for 
pharmaceutical and cosmetic purposes. Elastic vesicles showed superior properties in 
comparison with the conventional, rigid vesicles regarding the function potential and the 
interactions with the human skin. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers 
(NLC) are also much investigated for cutaneous administration. Flexible liposomes are used as 
delivery systems for topical applications in cosmetics as well. Since the shell material comprises 
triglycerides and phospholipids, when used in topical delivery, liposomes can facilitate absorption 
of the active ingredient into the epidermis and they also have the ability to transport active 
substances into the deeper skin layers. Micellar nanoparticles, which are liposome-like multi-
lamellar structures, have also been reported as skin delivery systems. Encapsulation techniques 
are also much used as skin delivery systems in topical cosmetic products. Encapsulation of actives 
for cosmetic and pharmaceutical applications have showed a wide range of applications, as the 
advantages of different encapsulation technologies were made evident. Other delivery systems, 
such as phytosomes, transferosomes, nanocrystals and cubosomes have also been reported 
(Chanchal et al., 2008; El Maghraby et al., 2008; Fairhurst et al., 2008; Wiechers, 2008; Kaur et 
al., 2007; Rosen, 2005; Barry, 2002; Flynn, 2002). 
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1.3.4. Encapsulating materials 
The efficacy of topically applied active ingredients clearly depends on the design of appropriate 
carriers and the type of vehicle used for their delivery, protection and release. The correct choice 
of the encapsulating material according to the intended application is essential, as it influences 
the encapsulation efficiency and the stability of the microparticles. Factors to be considered while 
selecting a wall material for topical applications include toxicity, biocompatibility, stability, 
viscosity and mechanical properties, compatibility between the active ingredient and the wall 
material, release of the active ingredient from the vehicle into the skin, enhancement of active 
penetration into the stratum corneum, intended particle size and microscopic properties of the 
surface of the microparticles and processing and economic factors. Since most encapsulating 
materials do not have all the required properties, a common practice involves a combination of 
wall materials (Silva et al., 2014b; Abla et al., 2013; Estevinho et al., 2013a). 
Encapsulating materials can be selected from a wide variety of natural and synthetic polymers. 
The most commonly used encapsulating materials include polysaccharides (gums, starches, 
celluloses, alginates, cyclodextrins, maltodextrins, chitosan), proteins (gelatin, casein, soy 
proteins), lipids (waxes, paraffin, oils), aliphatic polyesters (e.g. poly(lactic acid) – PLA), 
copolymers of lactic and glycolic acids (e.g. poly(lactic co-glycolic acid) - PLGA) and synthetic 
polymers (acrylic polymers, polyvinyl alcohol, poly(vinylpyrrolidone)). Inorganic materials, such as 
silicates, clays and polyphosphates, can also be used as second polymers (Lee et al., 2012; Tarimci, 
2011; Cattaneo, 2010; Pawar et al., 2010; Pedro et al., 2009; Wille, 2006; Matsuda et al., 1999).  
Biopolymers (natural polymers) and biodegradable polymers are the encapsulating materials with 
greater interest for applications in the field of skin delivery systems. These materials are natural, 
non-toxic,  non-reactive when in contact with the human tissues and can be broken down or 
metabolized and removed from the body via normal metabolic pathways, while other compounds 
can potentially accumulate in body tissues and cause irritation. Their properties are strongly 
defined by structural characteristics, including composition, molecular weight and nature of the 
chain end groups, and these polymers can be chemically functionalized to obtain improved 
properties (Ammala, 2013; Haddadi et al., 2008; Mishra et al., 2008; Stevanovic et al., 2007). 
Among numerous entrapping materials used for the encapsulation of pharmaceutical, cosmetic 
or food active ingredients, chitosan has received much attention for its excellent biocompatibility 
(Belščak-Cvitanović et al., 2011). Chitosan is a natural and biodegradable linear co-polymer 
polysaccharide consisting of β-(1–4)-linked D-glucosamine (2-amino-2-deoxy-D-glucose) and N-
acetyl-D-glucosamine (2-acetamido-2-deoxy-D-glucose) (Figure 6) (Silva, 2014; Ammala, 2013). 
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Chitosan is obtained by partial alkaline deacetylation of chitin (a N-acetyl-glucosamine polymer), 
which is the second most abundant natural polymer in nature. Chitin is synthesized by an 
enormous number of living organisms and is found predominantly in the exoskeletons shells of 
crustaceans, insects and other invertebrates (Silva 2014; Estevinho 2013a). 
 
Figure 6. Chemical structure of chitosan. 
Chitin is insoluble in aqueous solutions, while chitosan is soluble in acidic solutions due to free 
amino groups in protonated D-glucosamine units (Silva et al., 2014b; Sashiwa, et al., 2002). 
Chitosan can be produced with different deacetylation degrees (40–98%) and molecular weights 
(10–2000 kDa). These two characteristics have a significant role in chitosan properties (e.g. 
solubility, viscosity) and are extremely important when drug delivery is thought. The higher the 
deacetylation degree the more chitosan is soluble in water, and the higher the molecular weight 
more sustained is the release (Estevinho et al., 2013, 2012; Aranaz et al., 2009; Desai et al., 2006). 
Chitosan has unique and exceptional biological properties that promote its use as drug carrier. 
Moreover it is a renewable and inexpensive material with reactive amino functional groups, 
having the potential to be used in many different applications (Silva, 2014; Estevinho et al., 
2013a). Chitosan has been widely reported for use in topical and transdermal delivery systems 
largely due to its non-toxicity, biocompatibility and biodegradability (Silva, 2014; Ammala, 2013; 
Aranaz et al., 2009). It has also been reported that chitosan has the ability to enhance permeation 
across the skin by altering the structure of keratin and that it increases the water content of the 
stratum corneum and cell membrane fluidity. Further, due to its positive charge under slightly 
acidic conditions, it can depolarize the negatively charged cell membrane and in doing so, it 
decreases the membrane potential and drives the active component through the skin (Ammala, 
2013, Pawar et al., 2010; He et al., 2009). Previous studies also indicated that chitosan possesses 
various biological activities, such as antitumor and antioxidant effects, anti-cholesterolemic 
properties and antimicrobial activity against several pathogen and spoilage bacteria (Estevinho e 
al., 2013a; Fernandez-Saiz et al., 2009; Garcia et al., 2009; Sashiwa  et al., 2004; Muzzarelli, 1998; 
Tokoro et al., 1988). 
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Chitosan microparticle carriers have an exceptional potential for the delivery of bioactive 
compounds, since these systems are stable in contact with physiological fluids and barriers, 
protect the active compounds against adverse conditions and can control the release (Silva et al., 
2011). Microparticle properties depend on chitosan molecular weight and deacetylation degree 
and the mass ratio of chitosan to active ingredient. Water insoluble active ingredients are able to 
be delivered topically in the form of encapsulated chitosan-based microparticles, making it 
particularly appealing for topical delivery systems. In addition to topical delivery, chitosan systems 
have also been reported in oral and transmucosal delivery, and other biomedical, pharmaceutical 
and food applications, including for the delivery of natural antioxidants (Silva, 2014; Ammala, 
2013; Estevinho et al., 2013a; Belščak-Cvitanović, 2011; Harris et al., 2011; Kosaraju et al., 2006). 
In spite of the interesting advantages of chitosan, it is insoluble in water and organic solvents, 
only being soluble in acidic solutions, which frequently limits its application (Silva, 2014). It is 
possible, however, to modify chitosan structure in order to produce water soluble chitosan, which 
is easily soluble in neutral aqueous solutions. This increases the range of applicability of this 
compound, making it very useful as carrier for bioactive ingredients for pharmaceutical, cosmetic 
and food applications. Chitosan solubility can be improved by chemical modifications involving 
the introduction of hydrophilic functional groups, such as acetyl, carboxyl, hydroxyl, sulfuryl or 
phosphoryl groups, and also by a chemical, physical or enzymatic depolymerisation process, 
which leads to low molecular weight chitosan or oligomers. The localization of the new groups in 
the molecule of chitosan can change with the type and conditions of the reaction involved and 
the type of reagents used. Many chitosan derivatives can be produced, such as carboxymethyl 
chitosan, N-sulfofuryl chitosan, 5- methyl pyrrolidinone chitosan, dicarboxymethyl chitosan, and 
quaternized chitosan (Estevinho et al., 2014a, 2013a, 2013b; Sashiwa et al., 2004, 2002). 
Furthermore the chemical modification of chitosan is a powerful tool to control its properties, to 
control the interaction of the polymer with bioactive compounds, to enhance the loading 
capability and to tailor the release profile of the particles. Hence, chemically modified chitosan 
improves its bulk properties for the preparation of delivery systems, which enhances its versatility 
and applicability in the cosmetics sector. Nevertheless modified chitosan may compromise 
chitosan biodegradability, as the rate of degradation is generally inversely proportional to the 
extent of chemical modification (Silva, 2014).  
Considering the above factors, chitosan and modified-chitosan were selected as vehicles for this 
study. The combination of chitosan based particles with a high potent antioxidant compound 
could be a hope for future delivery of these agents, considering the important effect of oxidative 
stress in body tissues and oxidative degradation in cosmetic formulations.  
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1.3.5. Controlled release 
Encapsulation should allow the core to be isolated from the external environment until release is 
desired. Therefore, the release at the appropriate time and place is an extremely important 
property in the encapsulation process, improving the effectiveness and expanding the 
applications of compounds of interest. The main factors affecting the release rates are related to 
interactions between the wall material and the core. Additionally, other factors influence the 
release, including the ratio between the core and the wall material, particle size, the method of 
encapsulation and the medium where the release occurs (e.g. pH, ionic strength) (Nikkola, 2014). 
The main mechanisms that can be involved in the core release are diffusion, degradation, use of 
solvents, pH, temperature and pressure. The release of an active ingredient may be based on one 
or on a combination of release mechanisms and these can be time, site, rate and/or stimulus 
specific. Diffusion occurs especially when the microcapsule shell is generally intact, and the 
release rate is governed by the chemical and physical properties of the core and the shell material. 
Degradation release occurs when enzymes, such as proteases, carbohydrases and lipases, 
degrade proteins, polysaccharides or lipids, respectively. In contact with a solvent, the shell 
material can dissolve partly or completely, quickly releasing the core, or start to expand, favouring 
the release. The pH release can occur when pH changes result in alterations in the shell material 
solubility, enabling the release of the core. Changes in temperature can promote core release, 
either by temperature-sensitive release, where materials expand or collapse when a critical 
temperature is reached, or by fusion-activated release, which involves melting of the shell 
material due to temperature increase. Pressure release occurs when a pressure is applied to the 
capsule wall, e.g. the release of cosmetic active ingredients during friction against the skin upon 
application. Less common release mechanisms include ablation (slow erosion of the shell) and 
biodegradation. The different release mechanisms provide controlled, sustained or targeted 
release of the core material, and with a properly designed release system the active ingredient is 
released at the desired site, time and rate. (Dubey et al., 2009; Nack, 1970).  
The study of the controlled release mechanisms helps to overcome both the ineffective utilization 
and the loss of bioactives during the processing steps. Mathematical modelling of release profiles 
can help provide a scientific knowledge basis concerning the mass transport mechanisms that are 
involved in the control of substances release. The release of the active compound in an ideal 
system may follow zero, half or first order kinetics. The applicability of mathematical models to 
the controlled release of compounds is increasing in industrial applications (Estevinho et al., 
2013a). 
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 CHAPTER 2: STATE OF THE ART 
During the last decade there has been a growing interest in the formulation of new cosmetic, 
food and pharmaceutical products containing natural compounds with antioxidant activity and 
other beneficial properties. Unfortunately, due to their structure and nature, certain compounds 
such as polyphenols, in particular rosmarinic acid, are not stable and may interact easily with the 
matrices in which they are incorporated. Although the formulation of microparticles can offer an 
efficient solution to overcome such limitations, there are limited studies exploring the potential 
of encapsulation for rosmarinic acid delivery, and generally they are all very recent (Table 4).  
Regarding the cosmetic sector, Budhiraja et al. (2014) explored the topical antibacterial and anti-
inflammatory potential of rosmarinic acid, by developing a novel antiacne niosomal gel of RA. The 
RA-loaded niosomes were prepared by emulsion solvent evaporation3 and evaluated regarding 
their antimicrobial activity against Propionibacterium acnes and Staphylococcus aureus. The 
niosomes were incorporated in a niosomal gel for sustained delivery to bacteria infected cells and 
these formulations were studied regarding their antibacterial activity and release profile, where 
RA content was analysed by UV-Vis spectrometry. RA release from the niosomes was performed 
in phosphate buffer (PB) pH 5.5 and was found to be 70% after 12 h. RA release from the gel 
formulation was 50% after 24 h. Results stated that skin permeation and retention was higher for 
rosmarinic acid niosomal gel as compared to rosmarinic acid gel of equivalent amount of free RA. 
The results showed that RA and RA-loaded niosomes have powerful inhibitory potential against 
acne bacteria and can be used as a possible therapy against acne vulgaris.  
Kim et al. (2010) explored the potential of rosmarinic acid to prevent skin damage caused by free 
radicals, thereby reducing the risk of cancer and atherosclerosis. RA-loaded polycaprolactone 
(PCL) microparticles were prepared by emulsion solvent evaporation for applying RA to cosmetic 
formulations. Changes in the characteristics of PCL microparticles were investigated for searching 
the optimum RA loading conditions, where zwitterionic surfactant-PCL particles showed the 
smallest size distribution and highest association efficiency. The long-term stability of RA was 
evaluated until 8 weeks in cosmetic formulations by analysing RA content using high performance 
liquid chromatography (HPLC). It was shown that emulsions containing RA-loaded microparticles 
exhibited a better long-term stability of RA when compared with those containing only RA. 
                                                          
3 Encapsulating ingredients and surfactants are dissolved in a water immiscible organic solvent. The aqueous phase 
containing the active is added to the organic phase and the mixture is sonicated to form an emulsion, followed by the 
removal of the organic phase using a rotary vacuum evaporator. The active ingredient can also be added to the organic 
phase depending on solubility. Particles are formed during the evaporation of the organic solvent. 
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Encapsulated 
material 
Encapsulating Material 
Encapsulation 
Method 
Analytical Method Application Results Reference 
Rosmarinic acid 
Carnauba wax 
 
Surfactant: Tween 80 
Hot 
homogenization 
HPLC-DAD Food 
Association efficiency: 99% 
Particle size: 0.035–0.93 µm 
The properties were maintained throughout the 28 day 
of refrigerated storage, and no rosmarinic acid was 
released by the particles during refrigeration. 
Madureira et 
al., 2015 
Rosmarinic acid 
Witepsol wax 
 
Surfactant: Tween 80 
Hot 
homogenization 
HPLC-DAD Food 
Association efficiency: 99% 
Particle size: 0.27-1.4 µm 
Stability tests during 28 d in refrigerated conditions 
showed that the particles maintain their initial 
properties. 
Campos et al., 
2014 
Rosmarinic acid 
Niosomes: sorbitan (surfactant), 
cholesterol 
 
Organic solvent: chloroform 
Emulsion solvent 
evaporation 
UV-Vis 
Spectrometry 
Cosmetics 
Association efficiency: 65% 
Particle size: 0.81 µm 
RA release: 70% at 12 h (in PB pH 5.5), and 50% after 14 
h (in a gel formulation) 
Niosomes of RA were found to increase the skin 
permeation and retention of RA. Encapsulated RA was 
effective against S. aureus and P. acne. 
Budhiraja et 
al., 2014 
Rosmarinic acid 
Glycerol monostearate 
 
Surfactants: Tween 80, soya lecithin 
Stabilizer: hydrogenated soya 
phosphatidyl choline 
Hot 
homogenization 
UV-Vis 
Spectrometry 
Pharmaceutical 
Association efficiency: 62% 
Particle size: 0.15 µm 
RA release (in PBS): 97% at 14 h 
NP-treated rats significantly increased behavioural 
alterations and attenuated the oxidative stress as 
compared with the control group. 
Bhatt et al., 
2014 
Rosmarinic acid 
Carnuba wax 
 
Surfactant: Tween 80 
Hot 
homogenization 
HPLC-DAD Food 
Association efficiency: 99% 
Particle size: 0.035-0.94 µm 
The smallest, physical and thermally stable SLN were 
those for 1.5% lipid and 2.0% tween 80. 
Campos et al., 
2012 
Rosmarinic acid 
Polycaprolactone (PCL) 
Organic solvents: methylene chloride 
and acetone (9:1) 
Surfactants: polyvinyl alcohol, 
cetrimonium chloride, sodium laureth 
sulphate, cocamidopropyl betaine 
Emulsion solvent 
evaporation 
HPLC Cosmetics 
Association efficiency: 78% (max) 
Particle size: 7.0-14 µm 
Cosmetic cream formulation containing RA-loaded PCL 
microparticles showed a better long-term stability of the 
RA compared with those containing only RA. 
Kim et al., 
2010 
Table 4. Studies on the encapsulation of RA or rich sources thereof for industrial and medical applications. 
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Encapsulated 
material 
Encapsulated material 
Encapsulated 
material 
Encapsulated 
material 
Encapsulated 
material 
Encapsulated material 
Encapsulated 
material 
Rosmarinic acid 
 
Sage and Savory 
extract 
Chitosan 
 
Sodium tripolyphosphate 
Acetic acid 
Ionic gelation HPLC-DAD Pharmaceutical 
Association efficiency: 51% 
Particle size: 0.24 µm 
Antioxidant activity: 3.65 µmol TE 
Release (in PBS pH 7.4): ≈ 100% at 60 min 
All nanoparticles demonstrate to be safe without 
relevant cytotoxicity  
Silva, 2014 
Silva et al., 
2014b 
Rosemary 
extract 
Covalently-based network gels: 
PEG/β-CD and PEG/glycerol 
Reaction of 
isocyanate end-
capped PEG with β-
CD or glycerol 
HPLC-MS 
 
UV-Vis 
Spectrometry 
n.s. 
Release (in ethanol and water): 60% at 30min 
The rosemary extract was readily released from the 
polymeric gels; consequently the values of antioxidant 
activity corresponding to these samples were similar to 
that observed in solution 
Ionita el at., 
2014 
Rosemary 
extract 
Poloxamers 
 
Supercritical CO2 
Supercritical anti-
solvent 
HPLC-UV 
 
UV-Vis 
Spectrometry 
n.s. 
Product Yield: ≈ 100% (max) 
Particle size: 1.0-20 µm 
Release (in PB pH 6.8): ≈ 100% at 60 min 
Visentin et al., 
2012 
Raspberry leaf, 
Gawthorn, 
Ground ivy, 
Yarrow, Nettle 
and Olive leaf 
extracts 
Sodium alginate, Chitosan 
 
Cross-linking solution: calcium 
chloride, ascorbic acid 
Electrostatic 
extrusion 
HPLC-DAD 
 
UV-Vis 
Spectrometry 
Food 
Encapsulation efficiency: 80-89% 
Particle size: 10-90 µm 
Release (in water): ≈ 100% at 60 min 
Although the antioxidant stability of hydrogel 
microcapsules was deteriorated during refrigerated 
storage, which might be attributed to the instability of 
ascorbic acid, the obtained microbeads delivered 
significant biological activity and antioxidant potential. 
Belščak-
Cvitanović et 
al., 2011 
max: maximum obtained; n.s.: not specified; NP: Nanoparticles; SLN: Solid Lipid Nanoparticles; PCL: Polycaprolactone; PEG: Polyethylene glycol; β-CD: β-cyclodextrin; CO2: carbon dioxide; PB: phosphate buffer; 
PBS: phosphate buffered saline; HPLC-DAD: high performance liquid chromatography with diode array detection; HPLC-MS: high performance liquid chromatography with mass spectrometry; HPLC-UV: high 
performance liquid chromatography with ultraviolet detection; 
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The inclusion of antioxidants, or rich sources thereof (fruits, aromatic herbs, etc.) in foods is also 
becoming a common procedure in the food industry. Madureira et al. (2015) and Campos et al. 
(2012, 2014) produced and studied the potential of rosmarinic acid loaded particles for food 
applications. Campos et al. (2012) prepared RA loaded particles by a hot homogenization4 method 
using carnauba wax as lipid and polysorbate 80 as surfactant. The effects of lipid proportion (0.5-
1.5% w/v) and surfactant concentration (1.0-3.0% v/v) were evaluated, and it was shown that the 
smallest, physical and thermally more stable particles were formulations containing 1.0-1.5% lipid 
and 2.0% surfactant. However the association efficiency was high for all formulations (≈ 99%), 
which means that the entrapment does not change with the different formulations tested. 
Campos et al. (2014) prepared RA loaded particles using a hot homogenization method, where 
witepsol wax was used as lipid and polysorbate 80 as surfactant. Madureira et al. (2015) produced 
RA loaded particles by hot homogenization using carnauba wax as lipidic matrix and polysorbate 
80 as surfactant. The stability of both particles was tested during 28 days stored at refrigeration 
temperature (5 °C) and the results showed that the particles maintain their initial properties.  
Rosmarinic acid has also potential in the pharmaceutical field. Bhatt et al. (2014) investigated the 
potential use of RA loaded nanoparticles for the effective management of Huntington’s disease 
(a neurodegenerative disease) by nasal delivery. The RA loaded particles were prepared by hot 
homogenization, in which glycerol monostearate was used as lipid, polysorbate 80 and soya 
lecithin were used as surfactants and hydrogenated soya phosphatidyl choline as a stabilizer. In 
vitro RA release profile was studied in phosphate buffered saline (PBS) pH 6.8 by analysing RA 
content by UV-Vis spectrometry. Nasal delivery of the developed particles followed by the study 
of behavioural and biochemical parameters in Wistar rats was carried out. Sustained release was 
observed from the RA-loaded particles and the treatment significantly improved behavioural 
abnormalities and attenuated the oxidative stress in treated rats. RA release was found to be 97% 
at 14 h for the optimized formula. Therefore this formula is able to control the release of the drug 
for a longer period of time, which may ultimately reduce the dosing frequency and may enhance 
the effectiveness of the therapy. The nasal delivery of the particles produced significant 
therapeutic action as compared to intravenous application, which confirmed that the developed 
optimized RA-loaded particles formulation following the non-invasive nose-to-brain RA delivery 
is a promising therapeutic approach for the effective management of Huntington’s disease. 
                                                          
4 The wall material is warmed to a temperature above the melting point and the active ingredient is added to the 
melted matrix. The preparation is emulsified into an aqueous phase heated above the melting point of the wall material 
and homogenised (e.g. through ultrasonication). The resulting solution is left to cool at room temperature. 
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The potential application of encapsulated natural extracts containing rosmarinic acid, namely 
extracts of rosemary, has also been investigated, considering the benefits of this compound.  
Silva et al. (2014b) investigated the use of chitosan particles as stable and protective vehicles for 
ocular deliver of rosmarinic acid for medical applications. Chitosan particles incorporating RA and 
natural extracts were prepared by ionic gelation5 and characterized in order to evaluate their size, 
association efficiency, in vitro release, irritancy, toxicity and antioxidant activity. The RA release 
profile was evaluated in PBS pH 7.4 by HPLC and a fast release was observed in all formulations, 
reaching almost 100% at 60 min. Encapsulated RA exhibited good antioxidant activity, although 
lower antioxidant activity was observed in the particles comparing to the free compound. The 
results also confirmed the absence of particles cytotoxicity and irritancy in the eye. 
Visentin et al. (2012) studied the encapsulation of rosemary antioxidants with poloxamers by a 
supercritical anti-solvent process6 to protect the antioxidants and to improve its aqueous 
solubility. Total content of polyphenols was quantified and HPLC analyses were performed to 
verify the presence of some of the major rosemary antioxidants: carnosic and rosmarinic acid. 
The release of rosemary polyphenols from the particles was measured in isotonic phosphate 
buffer solution (pH 6.8) by UV-Vis spectrometry and it was shown that the total polyphenolic 
content was dissolved from the encapsulated product after 60 min. 
Belščak-Cvitanović et al. (2011) studied the potential of encapsulating natural extracts rich in 
phenolic antioxidants, including rosmarinic acid, in alginate–chitosan systems. The encapsulation 
of the extracts was performed by electrostatic extrusion7 and in order to increase the solubility 
of chitosan, ascorbic acid was used, which additionally increased the antioxidant potential of the 
encapsulated extracts. The phenolic profile (evaluated by HPLC), mineral content and antioxidant 
capacity of the original and encapsulated extracts were determined, as well as the release profile 
in water (total phenolic content analysed by UV-Vis spectrometry) and the size of the obtained 
particles. A fast release profile was observed, where total release of phenolic compounds 
occurred at 60 min. Although the antioxidant stability of the microparticles was deteriorated 
                                                          
5 Chitosan is dissolved in an acidic solution, to which an aqueous cross-linking agent solution is added. Inter- and intra-
cross-linking (gelation) of the protonated amine group on chitosan molecules with the negatively charged cross-linking 
agent anions occurs spontaneously leading to the formation of chitosan particles. 
6 The active ingredient precipitates from droplets of an organic solvent when in contact with a continuous phase of 
supercritical carbon dioxide (CO2) (anti-solvent). The organic solvent can be almost completely removed by simply 
flushing with supercritical CO2 and dry particles are produced after CO2 extraction step. 
7 Method based on the use of electrostatic forces to disrupt the liquid filament at the tip of a capillary/needle and to 
form a charged stream of small droplets. 
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during one month of refrigerated storage, which was attributed to the degradation of ascorbic 
acid, the obtained microparticles deliver significant biological activity and antioxidant potential. 
Ionita et al. (2014) evaluated the encapsulation and release properties of rosemary extract in 
covalently-based network gels obtained by the reaction of isocyanate end-capped polyethylene 
glycol (PEG) with β-cyclodextrin or glycerol. The antioxidant activity of rosemary extract 
entrapped in polymeric materials was analysed. The results showed that rosemary extract was 
readily released from the polymeric gels (60% after 30 min) and consequently the values of 
antioxidant activity corresponding to these samples were similar to that observed in solution. 
Although the materials and methods used, the parameters to be analysed and the applications 
intended in the described studies are significantly different to compare their results, generally all 
results revealed the potential of rosmarinic acid encapsulation, showing that RA may be stably 
and efficiently encapsulated and suggesting the need to explore new delivery systems to be 
applied topically to overcome the limitations of topical RA delivery and effectiveness. However 
this literature review did not allow to determine the best conditions to be used in the present 
study considering the application intended: preparation of RA loaded microparticles to be 
incorporated in cosmetic formulations at an industrial level, since small scale methods were 
employed, different release mediums were used or at different pH values, or the intended 
applications were different. 
Solvent evaporation and hot homogenization have been the most commonly used methods for 
rosmarinic acid encapsulation (Madureira et al., 2015; Bhatt et al., 2014; Budhiraja et al., 2014; 
Campos et al., 2014, 2012; Kim et al., 2010). However the spray drying process has been widely 
and successfully used as encapsulation method for industrial applications, namely for the 
encapsulation of natural antioxidants (Bakowska-Barczak et al., 2011; Harris et al., 2011; Sansone 
et al., 2011; Robert et al., 2010; Kosaraju et al., 2006). Spray drying advantages, as discussed, 
include large equipment availability, easy control of particle properties, easy large-scale 
production and low process cost. However this method has never been applied to rosmarinic acid 
encapsulation and it would be of great interest to evaluate the results. Hence in this work a spray 
drying process was used to encapsulate RA aiming at an industrial cosmetic application. 
Regarding the release profile of microencapsulated rosmarinic acid limited studies are available. 
Budhiraja et al. (2014) evaluated the release of RA from niosomes in PB pH 5.5 and Bhatt et al. 
(2014) evaluated RA release from solid lipid particles (SLN) in PBS pH 6.8. The results showed 70% 
and 97% of release at 12 h and 14 h, respectively. Silva et al. (2014b) studied the release of RA 
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and natural extracts from chitosan microparticles in PBS pH 7.4 and a fast release was observed 
reaching almost 100% in 60 min. Belščak-Cvitanović et al. (2011) and Visentin et al. (2012) 
evaluated the release of rosemary antioxidants from alginate-chitosan and poloxamers 
microparticles and both results showed a total release of the phenolic compounds after 60 min. 
The differences observed might be due to the different encapsulating agents, particle sizes, 
phenolic content, medium in which the particles were dispersed, pH values and temperatures 
used. Considering the interest of chitosan as encapsulating agent (Chapter 1: Section 1.3.4) and 
spray drying as encapsulation technique, it would be important to study the release of rosmarinic 
acid from chitosan microparticles prepared by spray-drying in matrices that simulate formulations 
for topical applications. Although previous studies report fast release profiles of RA encapsulated 
in chitosan particles (Silva et al., 2014b), which might not be the optimum behaviour for cosmetic 
applications, no release studies were performed in oily matrices or solutions balanced with skin 
pH mimicking cosmetic formulations, and it would be interesting to evaluate the results. 
Therefore in this work a spray drying process was used to encapsulate RA into chitosan particles 
and the RA release profile was evaluated in water (pH 5.5) and coconut oil to simulate cosmetic 
formulations. Coconut oil is a vegetable oil obtained from fresh, mature kernel of the coconut 
(Cocos nucifera) and it comprises various health and nutraceutical benefits, which made it popular 
in the scientific field.  Coconut oil is non-skin irritating and has already been used in emulsions for 
topical application. The main fatty acid in coconut oil is lauric acid (≈ 45%) which has been 
reported to have antiviral, antimicrobial and antioxidant activities (Suraweera et al., 2014). 
Coconut oil is mildly acidic to neutral, being in balance with skin pH. Although the skin pH is 5.5, 
the pH of cosmetic formulations can range between 5.5 and 7 (Rosen, 2005). 
For polyphenols and rosmarinic acid determination HPLC (Madureira et al 2015; Campos et al., 
2014, 2012; Silva et al., 2014b; Visentin et al., 2012; Belščak-Cvitanović et al., 2011; Kim et al., 
2010) and UV-Vis spectrometry (Bhatt et al., 2014; Budhiraja et al., 2014; Visentin et al., 2012; 
Belščak-Cvitanović et al., 2011) have been used. As HPLC can separate and identify compounds 
via retention and is generally more sensitive, accurate, precise and specific, less prone to 
interferences and works well with trace quantities, it was the analytical method firstly chosen for 
RA quantification in the present work.
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CHAPTER 3: WORK OUTLINE 
3.1. Aims of the thesis 
This project aims to encapsulate rosmarinic acid (RA) into biopolymer-based microparticles as 
means to overcome the limitation of RA in cosmetic formulations. The development and 
characterization of a sustained-release system for rosmarinic acid using a biodegradable polymer 
and the study of the release profile under topical delivery conditions are intended. 
Specific aims include developing and validating an analytical method for RA determination; 
preparing rosmarinic acid loaded microparticles by the spray-drying technique using different 
types of chitosan, a natural biodegradable polymer; characterizing the obtained microparticles; 
studying the controlled release of RA from the particles under topical delivery conditions (water 
and coconut oil as dispersing mediums, mimicking cosmetic formulations, both balanced with the 
skin pH) and analysing the antioxidant activity of the encapsulated RA. 
3.2. Thesis Organization 
This thesis is divided in 5 chapters and respective subchapters. A Background section is firstly 
presented, where a general introduction of the thesis theme is outlined and some of the reasons 
why it is a worthwhile question are identified. Chapter 1 is dedicated to a review, presentation 
and explanation about the theoretical concepts of the subjects and methodologies to be 
addressed in the thesis. Antioxidants, natural compounds and their relevance in cosmetic 
applications are discussed. The relevance of rosmarinic acid, which is present in plants such as 
rosemary (Rosmarinus officinalis), for such applications is reported. Microencapsulation, 
microencapsulation techniques, encapsulating materials and controlled release mechanisms are 
briefly described, as well as their application to topical delivery cosmetics. Chapter 2 provides 
a review of the state of the art relevant to this work, explicitly about the encapsulation of 
rosmarinic acid or rich sources thereof. Chapter 3 presents the aims of the work and the overall 
organization of the thesis. Chapter 4 describes the materials and methods used for the 
development, characterization and analysis of biopolymer microparticles encapsulating 
rosmarinic acid. In chapter 5 the results obtained are presented and discussed. The analytical 
methods for rosmarinic acid quantification are validated, the microparticles are characterized by 
size, shape, product yield and association efficiency, the antioxidant potential is assessed and the 
release profile under topical delivery conditions is studied. The final section presents the main 
conclusions of the developed work, indicates the limitations emerged and gives suggestions for 
future research. Additional information to the study is included in the Appendix section.
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CHAPTER 4: MATERIALS AND METHODS 
4.1. Materials 
4.1.1. Standards and Reagents 
Rosmarinic acid (Ref. 536954-5G) was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Chitosan of medium molecular weight (Ref. 448877-250G), with a viscosity of 200 mPa.s (1%, 25 
°C) was obtained from Sigma-Aldrich. Modified chitosan (pharmaceutical grade water soluble 
chitosan) (Ref. SH20091010) was obtained from China Eastar Group (Dong Chen, China). Modified 
chitosan (water soluble) was produced by carboxylation and had a deacetylation degree of 96.5% 
and a viscosity of 5 mPa.s (1%, 25 °C). Methanol and acetonitrile were obtained from VWR 
International (Radnor, PA, USA). Citric acid was purchased from Merck KGaA (Darmstadt, 
Germany). Acetic acid was obtained from Carlos Erba (Peypin, France) and ethanol (96%) from 
Aga (Prior Velho, Portugal). Coconut oil (Ref. C1758-500G) was purchased from Sigma-Aldrich. 
2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), peroxium persulfate and Trolox 
were obtained from Sigma-Aldrich. Deionised water was obtained in the laboratory using a Merck 
Millipore Milli-Q water purification equipment (Billerica, MA, USA).  
4.1.2. Equipment 
All weight measurements were performed using a Mettler Toldedo AG245 analytical balance 
(Columbus, OH, USA). Microencapsulation was performed using a BÜCHI B-290 advanced spray 
dryer (Flawil, Switzerland) with a standard 0.5 mm nozzle. Instrumental analysis of rosmarinic acid 
was performed using a Merck Hitachi Elite LaChrom (Tokyo, Japan) high performance liquid 
chromatograph equipped with a Hitachi L-7100 pump and L-7250 auto sampler, and coupled to 
a L-7450A diode array detector. HPLC analysis was conducted by using a Purospher® STAR RP-18 
endcapped LiChroCART® column (250 mm x 4.0 mm, 5.0 µm) (Merck KGaA), attached to a guard 
column (4.0 mm x 4.0 mm, 5.0 μm) of the same type. Rosmarinic acid quantification was also 
performed using a Jasco V-530 UV-Vis Spectrophotometer (Easton, USA), as well as the 
antioxidant activity assessment. pH measurements were performed using a 900 Multiparameter 
Water Quality Meter (A & E Lab; Guangzhou, China). Particle morphology was evaluated by 
Scanning Electron Microscopy, SEM (Fei Quanta 400 FEG ESEM/EDAX Pegasus X4M) and particle 
size distribution was measured by laser granulometry using a Coulter Counter-LS 230 Particle Size 
Analyser (Miami, FL, USA).  
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4.2. Methods 
4.2.1. Analytical methodology for rosmarinic acid quantification 
Rosmarinic acid was determined and quantified through high performance liquid 
chromatography with diode array detection (HPLC-DAD) and through UV-Vis spectrometry. HPLC 
was the methodology firstly chosen for RA quantification, but due to column blocking and damage 
caused by the microparticles, a UV-Vis spectrometry method was developed.  
Analytical Standard Preparation 
A stock standard solution of 10 g.L-1 of rosmarinic acid was prepared in methanol by accurately 
weighting 100 mg of RA reference standard using an analytical balance (Mettler Toldedo) into a 
10 mL volumetric flask. The stock solution was sealed with parafilm, wrapped in aluminium foil to 
protect from light, stabilized for 24 hours at 4 °C to ensure homogenization and stored at -20 °C. 
An intermediate standard solution of 1 g.L-1 of rosmarinic acid was prepared from the stock 
solution by dilution in distilled water into a 10 mL volumetric flask. The intermediate solution was 
stabilized for 2 hours at 4 °C before further standard preparation.  
For HPLC, six working standard solutions were prepared by dilution of the intermediate solution 
in filtered distilled water: 10, 15, 20, 30, 40 and 50 mg.L-1; and four working standards were 
obtained by dilution of the 50 mg.L-1 standard: 0.50, 1.0, 2.0 and 5.0 mg.L-1. Distilled water was 
filtered through 0.45 µm Nylon 66 filter membranes (Sigma-Aldrich). For UV-Vis spectrometry 
five working standard solutions were prepared by dilution of the intermediate solution in distilled 
water: 5.0, 8.0, 10, 15, 20 mg.L-1; and three working standards were obtained by dilution of the 
20 mg.L-1 standard: 0.50, 1.0 and 2.0 mg.L-1.All measurements were performed using 500 µL and 
50 µL SGE Syringes (Melbourne, Australia). Standards were stabilized for 2 hours before analysis. 
High Performance Liquid Chromatography 
All HPLC runs were performed using a Merck-Hitachi Elite LaChrom high performance liquid 
chromatograph equipped with a Hitachi L-7100 pump and a L-7250 auto sampler, and coupled to 
a L-7450A diode array detector. Results were acquired and processed with D-7000 Multi-HSM 
Manager Software for data acquisition (Merck-Hitachi). HPLC analysis was conducted by using a 
Purospher® STAR RP-18 endcapped LiChroCART® column, 250 mm in length and 4.0 mm in 
diameter, with 5.0 µm particle size (Merck KGaA), attached to a guard column (4.0 mm x 4.0 mm, 
5.0 μm) of the same type. The mobile phase, at a flow rate of 0.8 mL.min-1, consisted of 75% 10 
mM citric acid solution in distilled water (acidity adjusted to pH 2.6) and 25% acetonitrile. Distilled 
water was filtered through 0.45 µm filter (Nylon 66, Sigma-Aldrich) and both phases were 
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degassed, as well as all washing solutions. Rosmarinic acid chromatographic analysis was 
performed isocratically. The injection volume was 100 µL and the analysis was performed at room 
temperature (≈ 20 °C). Detection was performed by measuring the absorption at 330 nm.  
The development of the HPLC method was initially based on the method for determination of 
chlorogenic acids by Tfouni et al. (2014) but the conditions were investigated to provide a simple 
procedure with the best peak resolution regarding symmetry and tailing, appropriate run time 
and cost-effective analysis. Modifications to the original method include alteration of the mobile 
phase and chromatographic column. Five citric acid:acetonitrile ratios (90:10, 80:20, 75:25, 60:40 
and 50:50) and two flow rates (1.0 and 0.80 mL.m-1) were evaluated regarding the mobile phase. 
Ten external standards of rosmarinic acid were run (0.50, 1.0, 2.0, 5.0, 10, 15, 20, 30, 40 and 50 
mg.L-1) and the calibration curve was constructed, in the chromatographic conditions established 
above. Retention time was used to identify RA and the total peak area was used for quantification.  
UV-Vis Spectrometry 
All spectrometry analyses were performed using a Jasco V-530 UV-Vis Spectrophotometer. In 
order to determine the best detection wavelength for analysis, in which the maximum absorption 
occurs, rosmarinic acid (0.50 mg.L -1 in water and coconut oil) was scanned between wavelengths 
200 to 600 nm and the absorption spectra was obtained. Considering the maximum absorption 
wavelength from the spectra, detection was performed at 327 nm in all spectrometry analyses. 
Eight external standards of rosmarinic acid were analysed (0.50, 1.0, 2.0, 5.0, 8.0, 10, 15, 20    
mg.L-1) and two calibration curves were constructed: in distilled water and in coconut oil. The 
value of absorption at 327 nm was used to quantify rosmarinic acid. 
Analytical Methods Validation 
The HPLC and the UV-Vis spectrometry methods were validated, in order to demonstrate that 
these methods are suitable for quantitative determination of RA and ensure the reliability of the 
results. Validation performance parameters: quantification parameters (linearity, sensitivity and 
limits of detection and quantification) and reliability parameters (repeatability and intermediate 
precision) were determined. 
The linearity is the ability of a method to demonstrate that the results obtained are directly 
proportional to the concentration of the analyte in the sample within a specific range. The results 
of the standard solutions analysed (in duplicate) by each method were processed statistically to 
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determine the calibration curve equation (least squares method) and the correlation coefficient 
R2, using the Microsoft Excel 2013 software. The calibration curves were constructed plotting the 
total peak areas, for HPLC, and the values of absorption, for UV-Vis spectrometry, in the vertical 
axis and rosmarinic acid concentrations in the horizontal axis. The linearity should be evaluated 
from the analysis of at least 5 standard concentrations in a range factor superior to 10, and the 
correlation coefficient should be at least 0.99. The sensitivity of the method is expressed as the 
slope of the calibration curve. The validation of a calibration curve assumes that the following 
conditions are met: 
 analysis of at least 5 different standard concentrations  
 linearity range in a factor superior to 10 
 𝑅2 ≥ 0.99 
𝑠𝑎
𝑎
≤ 5% 
 b −  𝑡𝑠𝑏  <  0 <  b + 𝑡𝑠𝑏 
where a is the regression slope, b the intercept of the regression and sa and sb the respective 
standard deviations. 
The limit of detection (LOD) is the lowest amount of analyte in the sample that can be detected 
by the methodology being validated, while the limit of quantification (LOQ) is the lowest amount 
of analyte in a sample that can be determined with acceptable accuracy and precision. For HPLC 
LOD and LOQ were calculated at signal/noise ratio of 3 (S/N=3) and 10 (S/N=10), respectively, for 
the lowest standard concentration, using the following expression (Eq. 1):  
𝐿𝑂𝐷, 𝐿𝑂𝑄 = 𝐶 ×
𝑆
𝑁
×
𝑁
𝐻
    (Eq.1) 
where S/N is the signal/noise ratio (for LOD, S/N=3; and for LOQ, S/N=10), C is the sample 
concentration, N the noise value when the blank is analysed, and H the value of the signal when 
the sample is analysed. For UV-Vis spectrometry LOD and LOQ were determined based on the 
standard deviation of the response and on the slope of the calibration curve, using the following 
expressions (Eq. 2 and Eq. 3), respectively: 
𝐿𝑂𝐷 =
3×𝑠𝑏
𝑎
     (Eq. 2) 
𝐿𝑂𝑄 =  
10×𝑠𝑏
𝑎
     (Eq. 3) 
The precision describes the closeness of the results obtained in a series of measurements of the 
same sample. Precision is further subdivided into intra-day precision or repeatability, which 
assesses precision within a short period of time with the same analyst and instrumentation, and 
inter-day precision or intermediate precision, which measures the precision with time (often 
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days)  and may involve different analysts, equipment, and reagents. Precision was assessed by 
testing the repeatability of three different standard solutions (low, medium and high 
concentration: 2.0, 15 and 40 mg.L-1 for HPLC, and 1.0, 8.0 and 15 mg.L-1 for UV-Vis spectrometry) 
six times, and by intermediate precision, analysing the same three standard solutions three times 
on different days. Precision was expressed as coefficient of variation (CV%), and these values 
should be less than 5%.  
4.2.2. Preparation of RA-loaded microparticles 
Modified (water-soluble) chitosan solution was prepared with the concentration of 10 g.L-1 (1% 
w/v) by accurately weighting 1 g of modified chitosan (Mettler Toledo) into 100 mL a volumetric 
flask. Chitosan solution was prepared with the concentration of 10 g.L-1 (1% w/v) by accurately 
weighting 1 g of chitosan (Mettler Toledo) into 100 mL of 1% v/v acetic acid aqueous solution. A 
solution of 1 g.L-1 (0.1% w/v) of rosmarinic acid was prepared by accurately weighting 50 mg of 
RA (Mettler Toledo) into a 50 mL volumetric flask. All the solutions were prepared with deionised 
water and at room temperature. Encapsulation agent solutions were prepared on the day before 
encapsulation and kept overnight at room temperature under stirring (540 rpm) to ensure full 
saturation of the polymer molecules. Rosmarinic acid solution, also prepared on the day before 
encapsulation, was sealed with parafilm, wrapped in aluminium foil to protect from light and 
stabilized for 24 hours at 4 °C. 20 mL of rosmarinic acid solution was added and mixed with each 
encapsulation agent solution at a constant agitation speed of 540 rpm during 30 min at room 
temperature before encapsulation by spray-drying. Rosmarinic acid final concentration in the 
solutions was 2% (w/v). The mass ratio of rosmarinic acid to wall material was 1:20 (w/w). 
Microencapsulation was performed using a BÜCHI B-290 advanced spray dryer (Flawil, 
Switzerland) with a standard 0.5 mm nozzle. The mixtures were feed into the spray dryer at a flow 
rate of 4 mL.min-1 (15%) and an inlet temperature of 115 °C. Air pressure, aspiration rate and 
nozzle cleaner were set to 6.0 bar, 100% and 3, respectively. The outlet temperature is a 
consequence of the other experimental conditions and of the solution properties and was around 
60 °C. The operating conditions were previously optimized by Estevinho et al. (2014b) and were 
used accordingly. The dried powders were collected and stored in falcon tubes, wrapped in 
aluminium foil, and stored at 4 °C while waiting for further analysis.  
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4.2.3. Characterization of RA-loaded microparticles 
Product yield 
Product yield (%) was measured for each microencapsulation experiment and was expressed as 
the ratio of the mass of powder obtained at the spray-dryer output and the solid content of the 
initial infeed solution (mixture of the encapsulation agent solution and rosmarinic acid solution). 
Association efficiency 
Association efficiency (AE) was evaluated considering the amount of rosmarinic acid associated 
with the particles. The AE was calculated by the difference between the total rosmarinic acid used 
to prepare the particles, and the amount of residual rosmarinic acid in the solution right after 
dispersion of the particles in water. AE of rosmarinic acid in rosmarinic acid microparticles was 
obtained according to the following equation (Eq. 4):  
AE% =  
Total amount of rosmarinic acid − Free amount of rosmarinic acid
Total amount of rosmarinic acid 
× 100    (Eq. 4) 
Particle morphology and particle size distribution 
Particle morphology was evaluated by Scanning Electron Microscopy, SEM (Fei Quanta 400 FEG 
ESEM/EDAX Pegasus X4M). Samples of microparticles were gold coated under vacuum in a Jeol 
JFC 100 apparatus at Centro de Materiais da Universidade do Porto (CEMUP) and SEM analysis 
was performed at 15 kV with magnification of 100–30 000 x, for surface structure observation.  
Particle size distribution was measured by laser granulometry using a Coulter Counter-LS 230 
Particle Size Analyser. A small powder sample was suspended in ethanol and ultrasound-
irradiated for 10 s to avoid particle agglomeration. The particles were characterized by volume 
and number distribution using Laser Diffraction and Polarization Intensity Differential Scattering. 
The results were obtained as an average of two 60 s runs. 
4.2.4. Controlled Release study 
The study of rosmarinic acid release profiles from the obtained microparticles was performed in 
two different mediums: distilled water (pH 5.5) and coconut oil, to simulate vehicles for 
incorporation of microparticles for skin delivery in cosmetic formulations. 4 mg of the 
microparticles obtained were suspended in 4 mL of each medium and stirred at a constant 
agitation speed of 60 rpm at room temperature for water and at 28 ˚C for coconut oil to ensure 
a liquid state. Separate samples were produced and analysed at defined time intervals: 0.0 min, 
1.0 min, 2.0 min, 5.0 min, 10 min, 20 min, 30 min, 45 min, 1.0 h, 2.0 h, 4.0 h, 6.0 h and 24 h. The 
release analysis was accomplished by evaluating the amount of rosmarinic acid released from the 
particles over the specified time using the HPLC-DAD and UV-Vis spectrometry methods validated 
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previously (Section 4.2.1). Duplicate samples were analysed at each time. Before HPLC injections, 
samples were filtered first through a 0.45 μm filter (VWR International) and later through a 0.20 
μm filter (VWR International) using 3 mL syringes to ensure particle retention.  
4.2.5. Antioxidant activity Assessment 
The assay used to estimate the antioxidant capacity of the encapsulated rosmarinic acid was the 
ABTS radical scavenging assay. A stock solution included 7.4 mM ABTS (Sigma-Aldrich) aqueous 
solution and 2.6 mM potassium persulfate (Sigma-Aldrich) aqueous solution. The working 
solution was prepared by mixing equal quantities of the two stock solutions, and the mixture was 
allowed to react for 12 h at room temperature in the dark. The resulting solution was diluted by 
mixing 1 mL with 60 mL of methanol to obtain an absorbance of 1.10 ± 0.02 AU at 734 nm. The 
samples (150 μL) were then mixed with the prepared solution (2850 μL) (1:20 v/v) and allowed 
to react for 2 h in the dark. Samples consisted of RA loaded chitosan and modified chitosan 
microparticles at maximum release (after 4 h in aqueous solution) and RA reference standard free 
in solution in the concentration expected at maximum release, considering controlled release 
study results (19.6 mg.L-1). The absorbance was taken at 734 nm (Jasco V-530 UV-Vis 
Spectrophotometer). The reactivity of the antioxidants tested was compared to that of Trolox 
(Sigma-Aldrich), a synthetic analogue of vitamin E commonly used as antioxidant reference. The 
standard curve was linear between 25 and 400 μM Trolox and the results were expressed in μM 
Trolox equivalents (TE) (Thaipong et al., 2006). 
4.2.6. Quality assurance and control 
Rosmarinic acid is a powerful but sensitive antioxidant. Methanolic stock solution of RA was 
preserved in the freezer (-20 °C) and protected from light to avoid degradation. Aqueous 
intermediate solution and individual standards were prepared and analysed freshly, and were not 
stored longer than 24 h. RA microparticles were wrapped in aluminium foil to protect from light 
and stored at 4 °C. 
4.2.7. Waste treatment  
The waste generated in this work consisted of aqueous solutions containing rosmarinic acid, 
chitosan, modified chitosan and coconut oil. A mixture of methanol, ABTS and potassium 
persulfate was obtained during the antioxidant activity assessment. HPLC analysis generated 
solutions containing acetonitrile and traces of rosmarinic acid and citric acid. All these residues 
were collected in closed containers, properly labelled for further treatment by the Environmental 
Management System of FEUP – EcoFEUP.
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CHAPTER 5: RESULTS AND DISCUSSION 
To study the release profile of RA from the microparticles, analytical methods for RA quantitative 
determination had to be developed. In the first phase of this work the development and validation 
of the chromatographic (HPLC) method for rosmarinic acid determination was carried out. Given 
the obtained results of the controlled release study by chromatographic analysis, UV 
spectrometry methods were developed and validated. The results obtained for the validation of 
the mentioned analytical methods are gathered in subchapter 5.1: Analytical Methods Validation. 
After rosmarinic acid encapsulation into chitosan and modified-chitosan microparticles, these 
particles were characterized regarding particle size, shape and size distribution. The product yield 
of the encapsulation process and the association efficiency were also determined. These results 
are presented in subchapter 5.2: Rosmarinic acid encapsulation and characterization of the 
microparticles. 
The controlled release study of rosmarinic acid from the obtained particles was planned to best 
simulate topical delivery conditions and to study the consequent biopolymer-based 
microparticles behaviour over a spaced period of time, until 24 h. The study of the release profile 
was performed in water and coconut oil, to simulate vehicles for incorporation of microparticles 
for skin delivery in cosmetic formulations. The instrumental analysis for rosmarinic acid 
quantification was performed by HPLC, and later by UV-Vis spectrometry, considering 
instrumental problems of the chromatographic method. The results are gathered in subchapter 
5.3: Controlled Release. Finally the antioxidant activity of the encapsulated rosmarinic acid as 
compared to RA free in solution and Trolox (used as antioxidant reference) was assessed. The 
results are presented in subchapter 5.4: Antioxidant activity. 
5.1. Analytical Methods Validation 
Considering the need to evaluate the percentage of RA released from the microparticles during 
the controlled release studies, it was necessary to develop robust analytical methods for RA 
quantitative determination. As discussed in Chapter 2: State of the Art, both HPLC and UV-Vis 
spectrometry methods have been used for rosmarinic acid quantification. As HPLC allows the 
separation, identification and quantification of compounds, is less prone to interferences and is 
generally a very sensitive, precise and specific method, it was the analytical method firstly chosen 
for RA quantitative determination in this work 
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5.1.1. HPLC 
The development of the HPLC method for RA quantification was optimized to provide a simple 
procedure with the best peak resolution regarding symmetry and tailing, appropriate run time 
and cost-effective analysis. Different citric acid:acetonitrile ratios and flow rates were evaluated 
regarding the mobile phase. Mobile phase at a flow rate of 0.8 mL.min-1 and consisting of 75% 10 
mM citric acid aqueous solution (pH 2.6) and 25% acetonitrile was shown to be optimum. A 
chromatogram obtained for these optimum conditions is shown in Figure 7. The retention time 
of rosmarinic acid in these conditions was 11.02 ± 0.32 min. 
 
Figure 7. Chromatogram of rosmarinic acid (20 mg.L-1) analysed by HPLC-DAD at 330 nm. 
After the preliminary tests to optimize the chromatographic conditions, the analytical method 
was validated to ensure that the method accurately quantifies RA and produces valid and reliable 
results. Ten external standards of rosmarinic acid in a range of concentrations between 0.50 and 
50 mg.L-1 were injected in duplicate. The results allowed the construction of the calibration curve, 
which is presented in Figure A2, Appendix B.1. 
Validation performance parameters, including quantification parameters (linearity, sensitivity 
and limits of detection and quantification) and reliability parameters (repeatability and 
intermediate precision) were determined. 
Regarding the quantification parameters, the results are presented in Table 5. Concerning the 
linear response of the detector, the regression curve was linear in the studied concentration 
range. LOD and LOQ were satisfactory low, as their values were less than the lowest concentration 
of the calibration curve.  
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Table 5. Quantification parameters of the HPLC method for rosmarinic acid quantification. 
Linearity Range 0.50-50 mg.L-1 
Correlation 
coefficient (R2) 
0.9995 
Regression slope 
Sensitivity 
204568 L.mAU.mg-1 LOD 0.02 mg.L-1 
Regression intercept -3642 mAU LOQ 0.08 mg.L-1 
The linearity conditions for the validation of the calibration curve are presented in Table 6. The 
results obtained were very satisfactory since the linearity requirements were all met. 
Table 6. Linearity conditions for the validation of the HPLC calibration curve. 
Linearity parameter Required conditions Results obtained 
Number of standards ≥ 5 10 
Linearity factor range ≥ 10 100 
Correlation coefficient (R2) ≥ 0.9990 0.9995 
Slope error 
𝑠𝑎
𝑎
≤ 5% 0.76% 
Intercept confidence interval b −  𝑡𝑠𝑏  <  0 <  b + 𝑡𝑠𝑏  -40742 < 0 < 33457 
Reliability results are presented in Table 7, and in detail in Appendix B.1. Precision, expressed as 
the coefficient of variation (CV%), was assessed by testing the repeatability (intra-day precision) 
and the intermediate precision (inter-day precision) at different concentrations within the 
working range: low (2.0 mg.L-1), medium (15 mg.L-1) and high (40 mg.L-1) standard concentrations.  
Table 7. Reliability parameters of the HPLC method for RA quantification. 
RA standard concentration 
(mg.L-1) 
Precision (CV%) 
Repeatability Intermediate precision 
2.0 1.9 0.6 
15 2.2 0.7 
40 2.2 1.0 
 
From the results obtained it can be concluded that the detector used showed no significant 
response variations and that the precision was satisfactory, as all repeatability and intermediate 
precision results showed coefficients of variation values lower than 5%.  
5.1.2. UV-Vis Spectrometry 
Due to the mentioned instrumental problems of the HPLC method, a UV-Vis spectrometry 
method was developed. Firstly the absorption spectra of rosmarinic acid was obtained between 
wavelengths 200 to 600 nm, for both controlled release mediums (water and coconut oil) in order 
to determine the wavelength of maximum absorption in each medium (Figure 8). In water the 
results showed a maximum absorption at 327 nm. In the case of coconut oil, the band of 
maximum absorption was not clear, so detection was performed by measuring the absorption at 
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327 nm for all spectrometry analyses, since this value, obtained for the aqueous solution, is close 
to the UV maximum absorption wavelength of RA reported in the literature. 
  
Figure 8. Absorption spectra of RA (0.50 mg.L-1) between 200 and 600 nm for a) water and b) coconut oil. 
The UV-Vis Spectrometry analytical methods were also validated, in order to demonstrate that 
they are suitable for quantitative determination of RA and ensure the reliability of the results. 
Eight external standards of rosmarinic acid in a range of concentrations between 0.50 and 20     
mg.L-1 were analysed in duplicate. The results allowed the construction of the calibration curves, 
which are presented in Figure A3 (a and b), Appendix B.2. 
Validation performance parameters: quantification parameters (linearity, sensitivity and limits of 
detection and quantification) and reliability parameters (repeatability and intermediate 
precision) were determined. 
The results of the quantification parameters of the UV-Vis spectrometry method for RA 
quantification in water and coconut oil are presented in Table 8. Regarding the response, the 
regression curve was linear in the studied concentration range. LOD and LOQ were satisfactory 
low, as LOD values were less than the lowest concentration of the calibration curve, and LOQ 
values were lower than the concentrations analysed in the controlled release study. 
Table 8. Quantification parameters of the UV-Vis spectrophotometer for RA quantification in water and coconut oil. 
 Water Coconut oil 
Linearity Range 0.50-20 mg.L-1 0.50-20 mg.L-1 
Regression slope / Sensitivity 0.048 L.AU.mg-1 0.054 L.AU.mg-1 
Regression intercept 0.0057 AU 0.0047 AU 
Correlation coefficient (R2) 0.9991 0.9996 
LOD 0.38 mg.L-1 0.25 mg.L-1 
LOQ 1.27 mg.L-1 0.83 mg.L-1 
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The linearity conditions for the validation of the calibration curves are presented in Table 9. The 
results obtained were very satisfactory since the linearity requirements were all met. 
Table 9. Linearity conditions for the validation of the UV-Vis spectrometry calibration curves. 
Linearity parameter Required conditions 
Results obtained 
Water Coconut oil 
Number of standards ≥ 5 8 8 
Linearity factor range ≥ 10 40 40 
Correlation coefficient (R2) ≥ 0.999 0.9991 0.9996 
Slope error 
𝑠𝑎
𝑎
≤ 5% 1.26% 0.82% 
Intercept confidence interval b - tsb < 0 < b + tsb -0.0004 < 0 < 0.0118 -0.0002 < 0 < 0.0092 
Reliability results are presented in Table 10, and in detail in Appendix B.2. Precision, expressed as 
the coefficient of variation (CV%), was assessed by testing the repeatability (intra-day precision) 
and the intermediate precision (inter-day precision) at different concentrations within the 
working range: low (1.0 mg.L-1), medium (8.0 mg.L-1) and high (15 mg.L-1) standard 
concentrations.  
Table 10. Reliability parameters of the UV-Vis spectrophotometer for RA quantification in water and coconut oil. 
RA standard 
concentration 
(mg.L-1) 
Precision (CV%) 
Repeatability Intermediate precision 
Water Coconut oil Water Coconut oil 
1.0 4.9 5.0 1.5 2.7 
8.0 3.4 4.0 1.8 1.7 
15 0.5 1.1 0.4 0.5 
 
From the results obtained it can be concluded that  there was no significant response variations 
and that the precision was satisfactory, as all repeatability and intermediate precision results 
showed coefficients of variation values lower than 5%. The precision results in water were slightly 
better than those in coconut oil, possibly due to better homogenisation of the solution. 
5.2. Rosmarinic acid encapsulation and characterization of the microparticles 
5.2.1. Product yield 
Rosmarinic acid was encapsulated into chitosan and modified chitosan microparticles by a spray 
drying process. The product yield (quantity of powder recovered in relation to the amount of raw 
materials used) was 42.6% for chitosan and 39.8% for modified chitosan, which are satisfactory 
values for the technique applied and the scale that was used. The spray drying method has 
successfully been used by other authors for the encapsulation of compounds, such as natural 
antioxidants, with chitosan and other encapsulating agents for industrial applications with 
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product yields ranging from 24.1% to 82.3% (Bakowska-Barczak et al., 2011; Sansone et al., 2011; 
Desai et al., 2005). Bakowska-Barczak et al. (2011) showed that the product yield of the spray 
drying process depends mainly on the type of encapsulating agent used and the inlet temperature 
employed. On the other hand, if small quantities of raw materials are used when compared to 
the scale of the spray dryer, which is the case in the present study, several losses will occur 
throughout the equipment, leading to a lower product yield. Furthermore, the particles produced 
are of very small size, and there might be some particle aspiration by the vacuum system.  
5.2.2. Association efficiency 
The RA association efficiency (amount of rosmarinic acid associated with the particles) was 92.6% 
for chitosan microparticles and 59.6% for modified chitosan microparticles. The pH of chitosan 
microparticles formation was lower than the one of modified chitosan, as acetic acid was added 
in order to protonate chitosan amino groups and make chitosan more soluble in water. The more 
acidic pH favours the interaction of rosmarinic acid and chitosan, since at lower pH values the 
protonation of chitosan amino groups is higher and reversible ionic interactions between the 
carboxylate group (COO-) of rosmarinic acid (pKa = 3.57) and protonated amino groups (NH3+) of 
chitosan (pKa = 6.5) may occur (Figure 9). Therefore the preparation of chitosan microparticles in 
acidic pH led to the entrapment of higher amounts of rosmarinic acid, resulting in a higher 
association efficiency. Studies that encapsulated phenolic compounds in chitosan particles 
obtained association efficiencies in the range of 27% to 90%. (Dudhania et al., 2010; Kosaraju et 
al., 2006). The entrapment efficiency of chitosan particles can vary from about 20% to 100%, 
depending mainly on the chitosan molecular weight, the pH upon particle formation and the use 
of cross-linking agents (Peres et al., 2011).  
 
 
Figure 9. Possible reversible ionic interactions between COO- group of RA and NH3+ of chitosan. 
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5.2.3. Particle morphology and particle size distribution 
The prepared RA-loaded microparticles were analysed by scanning electron microscopy (SEM) for 
particle morphology analysis and laser granulometry to determine particle size distribution. 
Figure 10 shows SEM images of RA loaded chitosan and modified chitosan microparticles. The 
microstructural analysis confirmed a population of smooth, regular and spherical particles for 
modified chitosan. Chitosan particles showed to be regular and spherical in shape but have a 
more rough surface morphology, where indentations appeared on the surface of the 
microparticles. Other authors have reported the presence of wrinkles and indentations on the 
surface of spray dried chitosan microparticles (Harris et al., 2011; Kosaraju et al., 2006; Desai et 
al., 2005). Some agglomeration can also be observed from SEM image results. Similar morphology 
results were obtained by Silva (2004) for chitosan encapsulating RA and by other studies that 
encapsulated phenolic compounds in chitosan particles (Harris et al. 2011; Sansone et al., 2011; 
Kosaraju et al., 2006). 
  
  
Figure 10. SEM micrographs of RA loaded chitosan (A, C) and modified chitosan (B, D) microparticles. 
Amplified 10 000 (A, B) and 20 000 (C, D) times, beam intensity (HV) 15 kV, distance between the sample and the lens 
(WD) around 10 mm. 
RESULTS AND DISCUSSION 
 
46 
 
Particle size and size distribution are important parameters towards the development of suitable 
microcarriers for cosmetic purposes, as they influence active ingredient loading, the release 
profile and the stability of the active compound inside the microparticles. Particle size and size 
distribution can also influence in vivo distribution, biological fate, toxicity and the targeting ability 
of microparticle systems. Particle size distribution results are presented in Figure 11 and 12 and 
in Table 11. 
 
Figure 11. Size distribution in volume of RA microparticles produced with chitosan (a) and modified chitosan (b). 
  
Figure 12. Size distribution in number of RA microparticles produced with chitosan (a) and modified chitosan (b). 
Table 11. Particle mean diameter results by laser granulometry analysis. 
Microparticles 
Mean diameter (µm) 
Differential volume Differential number 
Chitosan - RA 4.2 0.8 
Modified Chitosan - RA 7.7 0.1 
Similar mean diameter values were obtained for both types of microparticles produced, with 
distributions close to normal. The results indicated that the volume distribution of 90% of the 
particles is below 7.8 µm for chitosan microparticles and 17.2 µm for modified chitosan 
microparticles. Number distribution of 90% of the particles is below 2.0 µm for chitosan 
microparticles and 0.3 µm for modified chitosan microparticles. Size distribution of chitosan 
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a b 
particles was found to more uniform, since volume distribution is closer to number distribution 
and the results are close to normally distributed, except for small amounts of larger particles, 
which may be explained by aggregation effects. Modified chitosan microparticles exhibited a less 
uniform distribution, where bigger particles or agglomerates are present and a high number of 
nanoscale particles exist. Average particle sizes in the range of 3.20 to 59.9 and similar particle 
size distributions were also reported in antioxidants encapsulation by a spray drying process 
(Harris et al., 2011; Peres et al., 2011; Sansone et al., 2011; Kosaraju et al., 2006).  
5.3. Controlled Release 
The controlled release study of rosmarinic acid from the obtained particles was planned to 
simulate topical delivery conditions and to study the consequent chitosan and modified chitosan 
microparticles behaviour over a spaced period of time, until 24 h. The study of the release profile 
was performed in water and coconut oil in order to simulate cosmetic formulations, both 
balanced with the skin pH (pH ≈ 5.5). The release analysis was accomplished by evaluating the 
amount of rosmarinic acid released from the particles over a specified time. 
The instrumental analysis for rosmarinic acid quantification was firstly performed by the HPLC 
method validated previously. However microparticles caused HPLC column blocking and damage, 
even with successive filtering and washing steps, and the controlled release results were not 
reliable. A chromatogram obtained after 10 min of release from chitosan and modified chitosan 
microparticles is presented in Figure 13, a and b, respectively. This analysis was only performed 
in water until 30 min of release, due to the unusable results obtained. However the 
chromatograms show a single peak for both types of microparticles, with retention times close 
to the one of rosmarinic acid. This indicates that the encapsulating agents do not interfere with 
the UV detection at the wavelength used, which is in accordance with chitosan UV absorption 
spectra reported in the literature (maximum absorption at 285 nm) (Sionkowska et al, 2013). 
 
 
Figure 13. Chromatogram of RA-chitosan (a) and RA-modified chitosan (b) microparticles after 10 min of release in 
water, analysed by HPLC-DAD at 330 nm. 
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Considering the unusable results obtained by the chromatographic method, a UV-Vis 
spectrometry method was developed, validated and used for RA determination. Figure 15 
compares the RA release profile from chitosan (a) and modified chitosan (b) microparticles in 
different mediums: water and coconut oil. Figure 16 compares the RA release profile from 
microparticles in water (a) and coconut oil (b) using different biopolymers: chitosan and modified 
chitosan. Generally the in vitro rosmarinic acid release profiles obtained for each formulation 
showed three phases: (1) a first initial burst release, possibly due to desorption of RA initially 
associated with microparticles on their surfaces by weak linkages to chitosan, (2) a constant 
sustained release of the remaining RA, resulting from the diffusion of RA through the polymer 
wall as well as its erosion, and (3) a plateau in RA concentration after complete release. 
RA loaded chitosan microcapsules exhibited a fast initial release (≈ 90% after 45 min), and a 
sustained behaviour until complete RA release at around 4 h. This profile was observed for 
chitosan microparticles, both in water and coconut oil, with no significant differences (Figure 15, 
a). Regarding modified chitosan microparticles (Figure 15, b), a fast complete release was 
observed (100% at 30 min) in water, but after 4 h the profile exhibited a decrease of RA in 
solution. The reasons for this decrease are unknown, but there might have been adsorption of 
RA into the biopolymer, potentiated by interactions between RA and the modified groups of 
chitosan. Hydrolysis of RA is also a possibility (Figure 14), however this behaviour was not 
observed for chitosan microparticles in water. RA loaded modified chitosan microparticles in 
coconut oil showed a slower release profile, with approximately 75% of release after 2 h. This 
difference in behaviour in water and coconut oil is due to modified chitosan good solubility in 
water. In this medium, modified chitosan is well soluble, the microparticles disintegrate and RA 
is released. In oil, modified chitosan is less soluble and RA stays entrapped longer. The same 
decrease in RA in solution was observed in coconut oil for modified chitosan microparticles. 
Figure 14. Hydrolysis reaction of rosmarinic acid. 
Comparing the RA release profile from microparticles using the two different biopolymers, is 
possible to see that in water, modified chitosan exhibits a faster release (100% after 30 min) when 
compared to chitosan particles (95% after 2 h), due to modified chitosan better solubility in water 
(Figure 16, a). On the other hand, as modified chitosan is less soluble in oil, chitosan 
microparticles showed a faster initial release (90% at 30 min) than modified chitosan particles 
(75% after 2 h) in the coconut oil medium (Figure 16, b). 
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Figure 15. Comparison of the RA release profile from chitosan (a) and modified chitosan (b) microparticles in different mediums: water and coconut oil. 
 
 
      
Figure 16. Comparison of the RA release profile from microparticles in water (a) and coconut oil (b) using different biopolymers: chitosan and modified chitosan.
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In general a fast release profile was observed during the in vitro release assay, which was in 
accordance with previous data. Silva et al. (2014b) studied the release of RA and natural extracts 
from chitosan microparticles in PBS pH 7.4 and a fast release was also observed, with an initial 
burst effect in the first 30 min and reaching almost 100% of release within 60 min. Belščak-
Cvitanović et al. (2011) and Visentin et al. (2012) evaluated the release of rosemary antioxidants 
from alginate-chitosan and poloxamers microparticles and both results showed a total release of 
the phenolic compounds after 60 min. However slower release profiles were observed in other 
studies. Deladino et al. (2008) prepared chitosan beads for the encapsulation of natural 
antioxidants, and the results showed a released around 35% at 3.5 h, which is significantly slower 
than the released observed in the present study. Dudhania et al. (2010) also demonstrated a 
complete release of polyphenols from chitosan particles within 4 h. Harris et al. (2011) 
encapsulated polyphenols in chitosan microparticles prepared by spray drying and 60% of 
polyphenols was delivered from microparticles after 4 h in pH 5.7 and between 40 to 45% in pH 
6.5. The higher release in lower pH was due to the better solubility of chitosan. Budhiraja et al. 
(2014) evaluated the release of RA from niosomes in PB pH 5.5 and Bhatt et al. (2014) evaluated 
RA release from solid lipid nanoparticles in PBS pH 6.8. The results showed 70% and 97% of 
release at 12 h and 14 h, respectively. This is significantly lower than the released amount in the 
present study, and may be due to the differences in particle size (nano scale versus micro scale).  
These preliminary release tests in water and coconut oil indicated that depending on the cosmetic 
application, aqueous or oily formulations, chitosan and modified chitosan could be used, 
respectively, as encapsulating agents for a more sustained release. However further studies 
should be done to obtain microparticles that control the release of rosmarinic acid more 
effectively, since for cosmetic applications a slower release is intended. The profile of compound 
release from microparticles can be affected by the method of encapsulation, the release medium, 
the pH and by the interactions between the drug, encapsulating agent and auxiliary ingredients 
added, and these factors should be optimized to obtain an optimum sustained release system. 
5.4. Antioxidant activity 
Rosmarinic acid is a phenolic compound with known antioxidant properties. The antioxidant 
activity of rosmarinic acid free in solution and encapsulated into chitosan and modified chitosan 
microparticles was tested using the ABTS radical scavenging assay, based on the reduction of a 
coloured oxidant (Figure 17). In this assay, by addition of sodium persulfate, ABTS is converted to 
its radical cation, which is blue/green in colour and absorbs light at 734 nm. The ABTS radical 
cation is reactive towards most antioxidants, including phenolic compounds and Trolox, a water 
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soluble synthetic analogue of vitamin E. During the reaction, the blue/green ABTS radical cation 
is reduced back to its colourless neutral form, and the reaction is monitored 
spectrophotometrically (Re et al. 1999; Walker et al., 2009). The reactivity of the antioxidants 
tested is compared to that of Trolox and expressed in µM TE. 
 
Figure 17. Oxidation of ABTS by potassium persulfate to generate radical cation ABTS•+ and its reaction with an 
antioxidant compound (AOH). 
Antioxidant capacity results for rosmarinic acid free in solution and encapsulated into chitosan 
and modified chitosan microparticles are presented in Table 12: 
Table 12. Antioxidant activity estimated by ABTS of RA free in solution and encapsulated into chitosan and modified 
chitosan microparticles. 
 Antioxidant activity (µM TE) a 
RA free in solution 342 ± 2 
RA-Chitosan microparticles 216 ± 8 
RA-Modified chitosan microparticles 232 ± 4 
aData corresponds to the mean ± standard deviation of triplicate measurements of different preparations. 
Comparing the antioxidant activity of the free and encapsulated rosmarinic acid, a decrease in 
the antioxidant capacity can be observed after the encapsulation process, possibly due to the 
partial entrapment of the antioxidant. However it is well known that microcarriers protect the 
antioxidants from degradation, increasing their bioavailability.  Nevertheless encapsulation into 
chitosan and modified-chitosan microparticles did not compromise the rosmarinic acid good 
antioxidant activity performance, showing that chitosan-based microparticles are good vehicles 
for RA regarding the antioxidant capacity outline. The results prove the feasibility of using 
chitosan particles as natural antioxidant carriers. This was in accordance with previous reports 
that have showed good antioxidant capacities of compounds in chitosan particles (Han et al., 
2012; Amorim et al., 2010) and prepared by a spray drying method (Bakowska-Barczak et al., 
2011; Peres et al., 2011).
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CONCLUSIONS 
In this study chitosan-based microparticles encapsulating rosmarinic acid were prepared by the spray 
drying method, in order to overcome its limitations in cosmetic applications. The particles were 
characterized, the controlled release profile was studied and the antioxidant capacity was assessed.  
This was the first study to successfully report a spray-drying technique for rosmarinic acid 
encapsulation into chitosan and modified chitosan microparticles. Satisfactory product yields of 42.6% 
and 39.8%, and association efficiencies of 92.6% and 59.6% were obtained for chitosan and modified 
chitosan particles, respectively. The prepared microparticles showed to be spherical in shape and 
small sizing (4.2 and 7.7 μm) for both biopolymers tested. Chitosan particles exhibited a rough surface, 
while for modified chitosan some agglomeration was observed, resulting in bigger particle sizes.  
An HPLC method with DAD detection for RA determination was developed and validated. All 
parameters were within the conditions proposed, indicating that this method was sensitive, linear (R2 
> 0.999) and precise (CV < 5%), with low detection and quantification limits (0.02 mg.L-1 and 0.08 mg.L-
1, respectively). However this method did not prove to be suitable for RA release analysis from 
biopolymer microparticles, since the particles caused column blocking and damage, even after 
filtering and washing steps. An UV-Vis spectrometry method for RA determination was developed and 
validated. Validation results indicated that this method was sensitive, linear (R2 > 0.999) and precise 
(CV < 5%), with low detection (0.38 mg.L-1 in water and 0.25 mg.L-1 in oil) and quantification (1.27 
mg.L-1 and 0.83 mg.L-1) limits. The proposed method was used to predict the association efficiency 
and the release profile of RA from chitosan and modified chitosan particles. 
This was the first study to investigate the controlled release profile of RA under simulated topical 
conditions, namely in oily matrices.  Controlled release studies of RA showed a fast release (100% at 
30 min) for modified chitosan particles in water, and a slower release (75% at 2 h) in oil. Chitosan 
particles showed a fast release (90% at 45 min) in both mediums. The results indicated that depending 
on the cosmetic application, aqueous or oily formulations, chitosan and modified chitosan could be 
used, respectively, as encapsulating agents, for a more sustained release.  
Antioxidant assessment showed that, although a lower antioxidant activity was observed in the 
microparticles (216 ± 8 µM TE and 232 ± 4 µM TE) comparing to the free compounds (342 ± 2 µM TE), 
chitosan-based microparticles still maintained the rosmarinic acid good antioxidant activity 
performance, while allowing its protection and control of the release profile. 
The efficient application of these microcarriers will certainly depend on the application. These 
preliminary tests reveal the potential of chitosan-based microsystems prepared by the spray-drying 
technique for RA delivery and prove that microparticles could be eligible vehicles to encapsulate RA 
and protect it, while maintaining its beneficial properties. However, if a topical delivery through 
cosmetic formulations is intended, a slower and more sustained release system should be optimized. 
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LIMITATIONS AND FUTURE WORK 
Several drawbacks emerged during the development of this work, which limited the results obtained. 
Availability of the equipment, in specific of the HPLC, degasification system and UV-Vis 
spectrophotometer, was a major limitation that delayed the obtainment of results. The first phase of 
this work, consisting of HPLC method development, took a very long time due to low equipment 
availability and long running time of each sample. As mentioned, HPLC column blocking by 
microparticles was a major limitation that obliged to the development and validation of a new method 
for RA quantitative determination and delayed all the results. Rosmarinic acid instability and low 
solubility in water was also a limitation that forced the daily preparation of fresh intermediate and 
standard solutions. Regarding the antioxidant activity assessment, a DDPH radical scavenging assay 
was performed for comparison with the ABTS assay results, but the results were not reliable since the 
quality of the DDPH reagent seemed to be compromised. 
As preliminary tests, the results in this study are significant and prove the success of RA 
microencapsulation, suggesting the need to explore new delivery systems for RA topical delivery. As 
discussed, if the incorporation in a topical cosmetic formulation is intended, a more controlled and 
sustained release system should be optimized. The profile of compound release from microparticles 
can be affected by the method of particles preparation, the release medium, the pH and by the 
interactions between the compound, encapsulating agent and auxiliary ingredients. In future work 
these parameters should be investigated and optimized to obtain a system with the intended 
properties. Different encapsulating agents could be tested, as well as other encapsulating techniques, 
and the addiction of cross-linking agents. Considering the low product yields obtained, possible due 
to the small amount of raw materials used, a scale up should be performed to minimize powder losses 
and to ascertain the yield of the spray drying process for the proposed encapsulation. The long-term 
stability of encapsulated RA over time could be investigated, by analysing RA content after a defined 
period of time (weeks or months). The interactions of RA with chitosan and modified chitosan during 
the process of encapsulation could be investigated using Fourier Transform Infrared spectroscopy 
analysis and thermal properties of the particles could also be evaluated. The analysis of the 
antimicrobial activity of encapsulated RA against selected cell lines would provide relevant 
information on the therapeutic potential of RA microsystems, and so would the evaluation of the anti-
inflammatory capacity. It would be interesting in future work to attempt and develop a suitable 
extraction method for phenolic compounds, including rosmarinic acid, from rosemary (Rosmarinus 
officinalis) or other natural sources of these compounds. Encapsulation of these antioxidant extracts 
could be performed, and the particles could be characterized and analysed regarding release profile 
and antioxidant activity. Controlled release studies of microparticles encapsulating RA and rich sources 
thereof could be performed in emulsions mimicking cosmetic formulations or even in commercial 
cosmetic topical formulations for real data. Skin permeation and retention studies could be 
performed, using Franz diffusion cells, and in vivo studies could be done in a final stage.  
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APPENDIX 
A. Biosynthetic pathway of rosmarinic acid 
Phenylalanine (1) is transformed to 4-coumaroyl-CoA (2) by the enzymes of the general phenylpropanoid 
pathway: phenylalanine ammonia-lyase (EC 4.3.1.5) (a), cinnamic acid 4-hydroxylase (EC 1.14.13.11) (b) 
and hydroxycinnamic acid:CoA ligase (EC 6.2.1.12) (c). Tyrosine (3) is metabolized to 4-
hydroxyphenyllactate (4) by tyrosine aminotransferase (EC 2.6.1.5) (d) and hydroxyphenylpyruvate 
reductase (e). The ester (5) can be formed from 4-coumaroyl-CoA and 4-hydroxyphenyllactate by the 
catalytic activity of rosmarinic acid synthase (f) with concomitant release of CoA. Microsomal hydroxylase 
activities introduce the hydroxyl groups at positions 3 and 3′ of the aromatic rings of the ester 4-coumaroyl-
4′-hydroxyphenyllactate giving rise to rosmarinic acid (6) (Figure A1) (Petersen, 2013; Sundaram, 2010; 
Petersen et al., 2009, 1993). 
 
Figure A1. Biosynthetic pathway for rosmarinic acid (Adapted from Petersen et al., 2009). 
PAL: phenylalanine ammonia-lyase, CAH: cinnamic acid 4-hydroxylase, 4CL: hydroxycinnamate:coenzyme A ligase, TAT: tyrosine 
aminotransferase, HPPR: hydroxyphenylpyruvate reductase, RAS: hydroxycinnamoyl-CoA:hydroxyphenyllactate hydroxycinnamoyl 
transferase, 3-H, 3’-H: hydroxycinnamoyl-hydroxyphenyllactate 3- and 3’-hydroxylases.  
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B. Analytical Methods Validation 
B.1. High Performance Liquid Chromatography 
B1.1. Calibration Curve 
 
Figure A2. Calibration curve for RA quantification in aqueous solutions by HPLC. 
B.1.2. Precision 
Table A1. Repeatability (CV%) of the HPLC method for RA quantification at three concentration levels. 
RA standard 
concentration (mg.L-1) 
Repetition 
(n) 
A (mAU) 
Average A 
(mAU) 
CV (%) 
2.0  
1 453557 
449762 1.9 
2 461270 
3 449008 
4 442536 
5 454677 
6 437522 
15 
1 3291114 
3224456 2.2 
2 3284589 
3 3293079 
4 3161315 
5 3161121 
6 3155520 
40 
1 8263001 
8287361 2.2 
2 8294719 
3 7957016 
4 8416748 
5 8311104 
6 8481576 
Table A2. Intermediate precision (CV%) of the HPLC method for RA quantification at three concentration levels. 
Day 
Repetition 
(n) 
2 mg.L-1 15 mg.L-1 40 mg.L-1 
A (mAU) CV (%) 
Average 
CV (%) 
A (mAU) CV (%) 
Average 
CV (%) 
A (mAU) CV (%) 
Average 
CV (%) 
1 
1 375126 
0.8 
0.6 
3162110 
1.4 
0.7 
8320615 
0.6 
1.0 
2 372278 3217069 8279939 
3 369016 3126498 8377044 
2 
1 388380 
0.5 
3191497 
0.5 
8213514 
0.2 2 387624 3180203 8188119 
3 391480 3213195 8205964 
3 
1 453557 
0.5 
3291114 
0.1 
8263001 
2.3 2 451270 3284589 7957016 
3 449008 3293079 8294719 
A = 204568 C - 3642
R² = 0,9995
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B.2. UV-Vis Spectrometry 
B.2.1. Calibration Curves 
 
Figure A3. Calibration curve RA quantification in water (a) and coconut oil (b) by UV-Vis spectrometry. 
B.2.2. Precision 
Table A3. Repeatability (CV%) of the UV-Vis Spectrometry method for RA quantification at three concentration levels. 
Medium 
RA standard 
concentration 
(mg.L-1) 
Repetition 
(n) 
Abs (AU) Average Abs (AU) CV (%) 
Water 
1 
1 0.0400 
0.0423 4.9 
2 0.0430 
3 0.0416 
4 0.0410 
5 0.0421 
6 0.0460 
8 
1 0.3990 
0.3885 3.4 
2 0.4001 
3 0.3900 
4 0.3634 
5 0.3897 
6 0.3890 
15 
1 0.7305 
0.7358 0.5 
2 0.7326 
3 0.7380 
4 0.7368 
5 0.7395 
6 0.7375 
Coconut oil 
1 
1 0.0280 
0.0282 5.0 
2 0.0271 
3 0.0286 
4 0.0263 
5 0.0285 
6 0.0304 
8 
1 0.4382 
0.4381 4.0 
2 0.4436 
3 0.4209 
4 0.4156 
5 0.4627 
6 0.4477 
15 
1 0.8233 
0.8300 1.1 
2 0.8289 
3 0.8196 
4 0.8307 
5 0.8462 
6 0.8314 
 
Abs = 0,0480 C + 0,0057
R² = 0,9991
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Table A4. Intermediate precision (CV%) of the UV-Vis spectrometry method for RA quantification at 3 concentration levels. 
Medium Day 
Repetition 
(n) 
1 mg.L-1 8 mg.L-1 15 mg.L-1 
A 
(mAU) 
CV (%) 
Average 
CV (%) 
A 
(mAU) 
CV (%) 
Average 
CV (%) 
A 
(mAU) 
CV (%) 
Average 
CV (%) 
Water 
1 
1 0.0400 
3.6 
1.5 
0.3990 
1.40 
1.8 
0.7305 
0.53 
0.4 
2 0.0430 0.4001 0.7326 
3 0.0416 0.3900 0.7380 
2 
1 0.0829 
0.2 
0.4961 
0.12 
0.4961 
0.12 2 0.0827 0.4973 0.4973 
3 0.0825 0.4967 0.4967 
3 
1 0.0766 
0.7 
0.3631 
4.03 
0.8074 
0.64 2 0.0777 0.3894 0.8174 
3 0.0774 0.3900 0.8099 
Coconut 
oil 
1 
1 0.0280 
2.6 
2.7 
0.4382 
2.73 
1.7 
0.8233 
0.57 
0.5 
2 0.0271 0.4436 0.8289 
3 0.0286 0.4209 0.8196 
2 
1 0.0183 
3.0 
0.4201 
1.19 
0.8022 
0.62 2 0.0187 0.4295 0.7989 
3 0.0194 0.4217 0.7925 
3 
1 0.0301 
2.4 
0.4476 
1.29 
0.8334 
0.24 2 0.0298 0.4508 0.8298 
3 0.0312 0.4589 0.8301 
 
C. Antioxidant Activity  
 
 
Figure A4. Linear regression for antioxidant activity estimated by ABTS method. 
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D. Poster Presentations 
Poster presented to 8th Meeting of Young Researchers from U.PORTO, in May 2015 
 
APPENDIX 
 
66 
 
Abstract of Poster to be presented at 6th Workshop on Green Chemistry and Nanotechnologies in 
Polymer Chemistry 
ENCAPSULATION OF ROSMARINIC ACID INTO CHITOSAN AND 
MODIFIED CHITOSAN MICROPARTICLES FOR TOPICAL DELIVERY 
 
F. Casanova, B. N. Estevinho, L. Santos*  
LEPABE, Departamento de Engenharia Química, Faculdade de Engenharia da Universidade do 
Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal 
*lsantos@fe.up.pt 
 
Introduction 
Topically applied antioxidants constitute important cosmetic active ingredients capable of both 
protecting skin cells against the damaging effects of reactive species, thus preventing skin aging 
and damage (including skin cancer), as well as protecting the cosmetic formulation against 
oxidative degradation. Recently, interest has increased considerably in finding naturally occurring 
antioxidants for cosmetic applications to replace synthetic antioxidants, which are being restricted 
due to their toxicity and side effects, e.g. carcinogenic effects [1, 2]. 
Natural matrices represent a rich source of biologically active compounds, such as antioxidants, 
vitamins and minerals, having a recognized potential for the development of cosmetic products 
[3]. In particular rosemary (Rosmarinus officinalis) extracts, herb native to the Mediterranean 
region in countries including Portugal, possess very useful antioxidant properties, which appear 
to be related to their content of phenolic compounds, amongst which rosmarinic acid was found 
to be one of the most important [4]. 
Rosmarinic acid (RA) is a naturally occurring phenolic compound commonly found in plants 
belonging to the Boraginaceae family and the subfamily Nepetoideae of the Lamiaceae family [5]. 
RA as number of interesting biological activities, including anti-inflammatory, anti-allergic, 
antimicrobial, antiviral, anxiolytic, neuro-protective, amongst others [6, 7, 8]. However the most 
important activities of rosmarinic acid are the high antioxidant activity and the anti-carcinogenic 
effects. RA helps to prevent skin aging and damage caused by free radicals, thereby reducing 
the risk of cancer [5]. Rosmarinic acid is therefore a compound of interest for cosmetic 
applications. However compatibility and stabilization are major concerns. Since antioxidants can 
be very unstable, they may become oxidized and inactive before reaching the target body site, 
hence the efficacy and benefit of an antioxidant is very much dependent on the delivery of the 
antioxidant to the organism. Transdermal delivery of rosmarinic acid through cosmetic 
formulations is a challenge due to various reasons, including instability, discoloration, poor 
solubility, low partition coefficient and poor absorption, constraining the transport across biological 
barriers and the inclusion in a cosmetic formulation [9].  
These issues can be solved by applying the microencapsulation technology, which provides the 
required technique for conversion of the antioxidant to an effective functional ingredient [8]. There 
are several techniques of microencapsulation, but one of the most used is the spray-drying 
process due to its low cost, availability of equipment and efficiency [10]. 
Therefore, in this work we pretend to microencapsulate rosmarinic acid with chitosan and modified 
chitosan by a spray-drying process and also to study the controlled release of RA under simulated 
conditions. 
 
Experimental 
Microencapsulation of the 20 mL of RA solution (1g/L) in 100 mL of each encapsulating agent 
solutions (10 g/L) was performed using a spray-dryer BÜCHI B-290 advanced (Flawil, 
Switzerland) with a standard 0.5 mm nozzle. The solutions containing the RA were spray-dried, 
under the following conditions: solution flow rates, air pressure and inlet temperature were set at 
4 mL/min (15%), 6.0 bar and 115 ºC, respectively. The outlet temperature is a consequence of 
the other experimental conditions and also of the solution properties and was around 60 ºC.  
The prepared microparticles were characterized (surface and size) by scanning electron 
microscopy (SEM).  
The release of RA from the obtained microparticles at different pH´s was accomplished by 
evaluating the RA content using HPLC/DAD analysis. Samples were taken at defined time 
intervals and analysis was performed on Merck Hitachi Elite LaChromatogragh (Tokyo, Japan) 
with a quaternary system of pumping (L-2130) which is equipped with LiChroCART® RP-18 end-
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capped (250x4 mm, 5 μm) column attached to a guard column (4x4 mm, 5 μm) of the same type 
and L-2200 auto sampler with L-2455 UV/vis spectrophotometry diode array detector at 332 nm. 
Mobile phase composition was eluent A: 10 mM citric acid solution, acidity adjusted to pH 2.6 and 
eluent B: acetonitrile. Injected volume was 100 𝜇L and the flow rate of analysis was 0.8 mL/min. 
The main validation parameters of the analytical method for RA were also determined. 
 
Results and discussion 
A product yield (mass ratios between the recovered powder and the quantity of raw materials 
used) ranging from 39.76% to 42.57% were obtained for the microparticles prepared with modified 
chitosan and chitosan, respectively. Microparticles with a mean diameter around 4 µm have been 
observed, for all the biopolymers tested (chitosan and modified chitosan). The microparticles 
formed with modified chitosan presented a very smooth surface, on the other hand the 
microparticles prepared with chitosan show a very rough surface (Fig. 1). 
     
Fig.1. SEM image: Detail of the microparticles prepared with chitosan (A) and modified chitosan (B). 
The quantification and the release of RA from the microparticles was evaluated by a methodology 
validated for this objective. A linear regression was obtained for a concentration range (0.5-50 
mg/L) with a correlation coefficient (R2) of 0.9995. The limit of detection (LOD) was 0.0004 mg/L. 
The method exhibited high repeatability as intra-day precisions of 0.99, 2.22 and 2.19% were 
achieved for low (2 mg/L), medium (15 mg/L) and high (40 mg/L) standard concentrations and 
the inter-day precisions were 0.59, 0.16 and 2.28% for low, medium and high standard 
concentrations, respectively.  
The controlled release studies showed different release profiles of the RA for each pH and for 
each encapsulating agent. 
 
Conclusions 
We concluded that it is possible to encapsulate RA using different types of chitosan, through a 
spray-drying process. Microparticles of RA with 3 µm were obtained for all the biopolymers tested. 
From the performed tests, the results are significant and prove the success of the RA 
microencapsulation for a topical delivery. 
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